###begin article-title 0
Nitrated alpha-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
###end article-title 0
###begin p 1
Conceived and designed the experiments: HG EB VP RM RB AR SS. Performed the experiments: EB VT RM RB AR CN. Analyzed the data: EB VP PC RM RB AR SS. Contributed reagents/materials/analysis tools: HG PC RM. Wrote the paper: HG SP EB RM RB AR.
###end p 1
###begin p 2
###xml 58 66 <span type="species:ncbi:9606">Children</span>
Current address: Department of Pediatrics, North Carolina Children's Hospital, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
The neuropathology of Parkinson's disease (PD) includes loss of dopaminergic neurons in the substantia nigra, nitrated alpha-synuclein (N-alpha-Syn) enriched intraneuronal inclusions or Lewy bodies and neuroinflammation. While the contribution of innate microglial inflammatory activities to disease are known, evidence for how adaptive immune mechanisms may affect the course of PD remains obscure. We reasoned that PD-associated oxidative protein modifications create novel antigenic epitopes capable of peripheral adaptive T cell responses that could affect nigrostriatal degeneration.
###end p 4
###begin title 5
Methods and Findings
###end title 5
###begin p 6
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">Mice</span>
###xml 746 750 <span type="species:ncbi:10090">Mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
Nitrotyrosine (NT)-modified alpha-Syn was detected readily in cervical lymph nodes (CLN) from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxicated mice. Antigen-presenting cells within the CLN showed increased surface expression of major histocompatibility complex class II, initiating the molecular machinery necessary for efficient antigen presentation. MPTP-treated mice produced antibodies to native and nitrated alpha-Syn. Mice immunized with the NT-modified C-terminal tail fragment of alpha-Syn, but not native protein, generated robust T cell proliferative and pro-inflammatory secretory responses specific only for the modified antigen. T cells generated against the nitrated epitope do not respond to the unmodified protein. Mice deficient in T and B lymphocytes were resistant to MPTP-induced neurodegeneration. Transfer of T cells from mice immunized with N-alpha-Syn led to a robust neuroinflammatory response with accelerated dopaminergic cell loss.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
These data show that NT modifications within alpha-Syn, can bypass or break immunological tolerance and activate peripheral leukocytes in draining lymphoid tissue. A novel mechanism for disease is made in that NT modifications in alpha-Syn induce adaptive immune responses that exacerbate PD pathobiology. These results have implications for both the pathogenesis and treatment of this disabling neurodegenerative disease.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Dauer1">[1]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Klockgether1">[2]</xref>
###xml 530 533 530 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Dauer1">[1]</xref>
###xml 710 713 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Spillantini1">[3]</xref>
Parkinson's disease (PD) is a common progressive neurodegenerative disease clinically characterized by resting tremor, muscle rigidity, bradykinesia, and postural instability [1]. PD is sporadic and of unknown cause although host genetics, environmental cues, aging, impaired energy metabolism and oxidative stress are linked to disease onset and progression [2]. Pathologically, PD is characterized by degeneration of dopaminergic cell bodies in the substantia nigra pars compacta (SNpc) and their associated caudate projections [1]. Nonetheless, the pathological hallmark of PD is cytoplasmic inclusions of fibrillar, misfolded proteins called Lewy bodies composed principally of alpha-synuclein (alpha-Syn) [3].
###end p 10
###begin p 11
###xml 226 229 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Spillantini1">[3]</xref>
###xml 231 234 227 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Sidhu1">[4]</xref>
###xml 236 239 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Paxinou1">[5]</xref>
###xml 241 244 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Weinreb1">[6]</xref>
###xml 246 249 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Eliezer1">[7]</xref>
###xml 251 254 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Uversky1">[8]</xref>
###xml 372 375 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Kruger1">[9]</xref>
###xml 377 381 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Polymeropoulos1">[10]</xref>
###xml 383 387 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Zarranz1">[11]</xref>
###xml 542 546 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-ChartierHarlin1">[12]</xref>
###xml 548 552 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Singleton1">[13]</xref>
###xml 780 784 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hodara1">[14]</xref>
###xml 786 790 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Uversky2">[15]</xref>
###xml 792 796 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Uversky3">[16]</xref>
###xml 798 802 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Yamin1">[17]</xref>
###xml 995 999 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Wersinger1">[18]</xref>
###xml 1001 1005 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Zhang1">[19]</xref>
###xml 1007 1011 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Croisier1">[20]</xref>
###xml 1121 1125 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Dringen1">[21]</xref>
###xml 1270 1274 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Ischiropoulos1">[22]</xref>
alpha-Syn is a 140-amino acid (aa), natively unfolded, soluble protein that is localized in the pre-synaptic terminals of neurons of the central nervous system (CNS), where it interacts with and may regulate synaptic vesicles [3], [4], [5], [6], [7], [8]. Three missense mutations (A53T, A30P and E46K) in the gene encoding alpha-Syn are linked to dominantly inherited PD [9], [10], [11]. Moreover, multiplication of the wild-type (WT) gene has also been linked to PD, suggesting that the level of alpha-Syn is an important pathogenic factor [12], [13]. Such familial cases are rare and in sporadic PD, there is no genetic aberration of alpha-Syn. However, it has been proposed that post-translational modifications such as nitration enhances WT alpha-Syn propensity to aggregate [14], [15], [16], [17]. Oxidized and aggregated alpha-Syn, when released from dying neurons, may stimulate scavenger receptors on microglia resulting in their sustained activation and dopaminergic neurodegeneration [18], [19], [20]. Moreover, activated microglia generate nitric oxide and superoxide that rapidly react to form peroxynitrite [21] which can then traverse cell membranes resulting in 3-nitrotyrosine (NT) formation, DNA damage, mitochondrial inhibition, or lipid peroxidation [22].
###end p 11
###begin p 12
###xml 160 164 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Ohmori1">[23]</xref>
###xml 166 170 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Mevorach1">[24]</xref>
###xml 172 176 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-CasciolaRosen1">[25]</xref>
###xml 178 182 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Amoura1">[26]</xref>
###xml 184 188 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Burkhardt1">[27]</xref>
###xml 190 194 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Utz1">[28]</xref>
###xml 196 200 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Doyle1">[29]</xref>
###xml 412 416 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Birnboim1">[30]</xref>
###xml 690 694 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Gendelman1">[31]</xref>
###xml 901 905 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Kipnis1">[32]</xref>
###xml 1041 1044 1033 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBP</sub>
###xml 1284 1288 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Benner1">[33]</xref>
###xml 1539 1543 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Masliah1">[34]</xref>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1342 1347 <span type="species:ncbi:9606">human</span>
###xml 1358 1373 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1388 1393 <span type="species:ncbi:9606">human</span>
###xml 1721 1726 <span type="species:ncbi:9606">human</span>
We now propose that modified "self" epitopes as neo-epitopes, including NT modifications within alpha-Syn, can bypass or possibly break immunological tolerance [23], [24], [25], [26], [27], [28], [29] and activate peripheral leukocytes in draining lymphoid tissue. In keeping with this, NT-modifications incorporated into self-peptides were sufficient to evade immunological tolerance as was previously reported [30]. The recruitment of activated T cells, specific for disease-associated protein modifications in alpha-Syn, may, in turn, promote a toxic microglial phenotype. The role of the adaptive immune system is becoming increasingly important in "non-autoimmune" diseases of the CNS [31]. Research in traumatic and neurodegenerative models have suggested a neuroprotective role for T and B cells within the CNS and that manipulation of the peripheral immune system can affect neurodegeneration [32]. Our own studies demonstrated that immunization of mice with glatiramer acetate generate T cells that recognize myelin basic protein (TMBP), secrete interleukin (IL)-10, IL-4, and transforming growth factor (TGF)-beta, and confer protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurodegeneration presumably by suppression of microglial activation [33]. Antibodies generated through active immunization of human alpha-Syn transgenic mice with purified human alpha-Syn protein reduced alpha-Syn aggregation in cell bodies and terminals, and was associated with protection of dopaminergic nerve terminals [34]. The conclusions were that anti-alpha-Syn antibodies target the aggregated protein to lysosomal pathways for degradation and that the strategy could be applied for treatment of human disease. That work was conducted however in an animal model of PD that lacks a neuroinflammatory component. As such, the study did not address the cellular arm of the immune system, which likely requires cytokine and chemokine gradients for efficient cell entry into diseased regions. Nevertheless, the work of Masliah et al., 2005 supports the potential importance for adaptive immunity and for immune-based strategies for the treatment of PD. Certainly, research activities into the potential use of alpha-Syn as an immunogen will require further study.
###end p 12
###begin p 13
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
Here, we report that NT-modified CNS antigens drain to the deep cervical lymph nodes (CLN) of mice following exposure to MPTP. Moreover, antigen-presenting cells (APC) within CLN increase surface expression of major histocompatibility complex (MHC) class II, initiating the molecular machinery necessary for efficient antigen presentation. The differential outcome on the susceptibility to MPTP-induced dopaminergic neurodegeneration amongst WT and severe combined immunodeficient (SCID) mice suggest a functional link of the adaptive immune system to MPTP-induced neurotoxicity. We further demonstrate in mice of two disparate haplotypes, that adoptive transfer of T cells from syngeneic WT donors immunized with nitrated alpha-Syn (N-alpha-Syn) prolongs MPTP-induced dopaminergic neuronal loss and hence warrants caution against the use of N-alpha-Syn or self-proteins that are prone to nitrate modifications for vaccine-based PD therapies.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
Animals
###end title 15
###begin p 16
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 82 86 82 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</sup>
###xml 77 86 77 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prkdc<sup>scid</sup></italic>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 158 159 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 148 159 148 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2<sup>k</sup> H2-T18<sup>a</sup></italic>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
Male 6-7 week old, WT C57BL/6J (stock 000664, denoted as B6) (H-2b), B6.CB17-Prkdcscid/SzJ (stock 001913, herein denoted as SCID) (H-2b) and B10.BR-H2k H2-T18a/SgSnJ (stock 000465, herein denoted as B10.BR) (H-2k) mice were purchased from Jackson Laboratories (Bar Harbor, ME). All animal procedures were in accordance with National Institutes of Health (NIH) guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Nebraska Medical Center (UNMC).
###end p 16
###begin title 17
MPTP Intoxication
###end title 17
###begin p 18
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Przedborski1">[35]</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
For chronic intoxication, B6 mice received 5 intraperitoneal (i.p.) injections at 24 hr intervals for 5 days of either vehicle (PBS, 10 ml/kg) or MPTP-HCl (30 mg/kg of free base in PBS) (Sigma-Aldrich, St. Louis, MO). For acute intoxication, mice received 4 i.p. injections, one every 2 hr, of either vehicle (PBS, 10 ml/kg) or MPTP-HCl (18 mg/kg of free base in PBS for B10.BR mice, 14 or 18 mg/kg for B6 mice). At selected time points following MPTP intoxication, mice were sacrificed and brains processed for subsequent analyses. MPTP handling and safety measures were in accordance with published guidelines [35].
###end p 18
###begin title 19
Immunohistochemistry
###end title 19
###begin p 20
###xml 982 986 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Benner1">[33]</xref>
###xml 988 992 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Wu1">[36]</xref>
###xml 1092 1096 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Schmued1">[37]</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 485 491 <span type="species:ncbi:9986">rabbit</span>
###xml 568 571 <span type="species:ncbi:10116">rat</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 631 634 <span type="species:ncbi:10116">rat</span>
###xml 684 687 <span type="species:ncbi:10116">rat</span>
###xml 718 721 <span type="species:ncbi:10116">rat</span>
At the time points indicated following MPTP intoxication, mice were transcardially perfused with 4% paraformaldehyde (PFA) in 0.1 M PBS using 0.9% saline as vascular rinse. Brains were post-fixed in 4% PFA overnight, kept in 30% sucrose for 2 days, snap frozen, embedded in OCT compound, and 30 microm sections cut on a cryostat (CM1900, Leica, Bannockburn, IL). The sections were collected in PBS and processed free-floating. Primary antibodies used for immunohistochemistry includes rabbit anti-TH antibody (1:2000; Calbiochem/EMD Biosciences, Inc., San Diego, CA), rat anti-mouse CD11b or Mac-1 (1:1,000; Serotec, Raleigh, NC), rat anti-CD3 (1:800; BD Pharmingen, San Diego, CA,), rat anti-CD4 (BD Pharmingen), and rat anti-CD8 (BD Pharmingen). Immunostaining was visualized using diaminobenzidine (Sigma-Aldrich) as the chromogen and mounted on slides. TH, CD3-, CD4- and CD8-immunostained brain sections were counterstained with thionin (Sigma-Aldrich) as previously described [33], [36]. Fluoro-Jade C (Chemicon International, Inc., Temecula, CA) was used to stain degenerating neurons [37] and was detected as green fluorescence by fluorescence microscopy with FITC filter (Eclipse E800, Nikon, Inc., Melville, NY).
###end p 20
###begin title 21
Stereology of TH-Positive Neurons
###end title 21
###begin p 22
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Benner1">[33]</xref>
Total numbers of Nissl- and TH-stained neurons throughout the entire SNpc were counted stereologically in a blinded fashion with Stereo Investigator software (MicroBrightfield, Williston, VT) using the Optical Fractionator probe module as previously described [33].
###end p 22
###begin title 23
Cloning alpha-Syn and 4YSyn
###end title 23
###begin p 24
###xml 1250 1257 1234 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 1250 1257 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Total RNA from adult C57BL/6 mouse brain was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The full-length mouse alpha-Syn gene (504 bp) and 120 bp length encoding the C-terminal portion (4YSyn) was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using Platinum Taq DNA Polymerase High Fidelity (Invitrogen). The 5' primer was designed to introduce a Nde1 site at position 1. This fragment was blunt cloned into the pZero-1 (Invitrogen) Eco RV site using standard cloning procedures. Transformed cells were plated on low salt agar containing Zeocyn and 3 mM IPTG. Colonies were screened using colony PCR with alpha-Syn primers. Colonies containing the full-length mouse alpha-Syn gene or the 3' fragment encoding 4YSyn were grown overnight and plasmid DNA was isolated using standard mini-prep (Invitrogen). The gene was digested out of pZero with Nde1 and Xho1 and subcloned into the Nde1 and Xho1 sites in the pET-28a prokaryotic expression vector using DH5-alpha cells. Colonies were screened using colony PCR. Purified plasmids were submitted to the UNMC core facility for sequence confirmation. Plasmids containing the complete sequence were transformed into BL-21 E. coli cells for expression. Frozen glycerol stocks were maintained at -80degreesC.
###end p 24
###begin title 25
4YSyn Expression
###end title 25
###begin p 26
###xml 369 372 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
Glycerol stocks were streaked on Luria-Bertani (LB) agar plate containing 30 microg/ml kanamycin. A single colony was inoculated into LB broth containing 30 microg/ml kanamycin, grown for 8 hrs, and stored at 4degreesC until the following day. The starter culture was diluted 1:100 into fresh liquid medium containing 30 microg/ml kanamycin and allowed to grow to an OD600 = 0.6. Expression of recombinant protein was induced by the addition of 3 mM IPTG with continued incubation for 3 hrs at 37degreesC. Following induction, cells were centrifuged, weighed, and stored at -80degreesC until purification protocol was resumed. >90% of detectable 4YSyn was found in the soluble fraction.
###end p 26
###begin title 27
Protein Purification and Nitration
###end title 27
###begin p 28
###xml 671 672 665 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 674 675 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 734 735 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 737 738 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 808 809 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 812 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1149 1150 1135 1136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1152 1153 1138 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cell lysis was performed with Bug Buster reagent (Novagen/EMD Biosciences, Inc., San Diego, CA) at 5 ml/g cells with addition of EDTA-free protease inhibitor cocktail (Calbiochem). Benzonase nuclease (Novagen) was added to reduce viscosity during lysis following manufacturer's instructions. Insoluble cell debris was removed by centrifugation at 16,000xg for 20 min at 4degreesC. The soluble fraction was directly subjected to column affinity chromatography and was carried out in the following steps: His-tagged protein was bound to Ni-NTA His Bind Resin (Novagen) in Bug Buster reagent with the addition of imidazole (10 mM). The column was washed first with 50 mM NaH2PO4/300 mM NaCl/20mM imidazole, pH 8.0 and then with 50 mM NaH2PO4/300 mM NaCl/35mM imidazole, pH 8.0. Elution was carried out 50 mM NaH2PO4/300 mM NaCl/250 mM imidazole pH 8.0. Samples were separated by SDS-PAGE and stained with Brilliant Blue G-Colloidal Coomassie stain (Invitrogen) to confirm purity of the eluted fraction. Full-length alpha-Syn and 4YSyn were visualized by silver stain (Silver Xpress, Invitrogen). Purified full-length alpha-Syn was dialyzed in 50 mM NaH2PO4 buffer. Thrombin cleavage was carried out using biotinylated thrombin cleavage capture kit (Novagen) following manufacturer's instructions. Cleaved His-tags were removed with Ni-NTA resin. His-tag free full-length alpha-Syn and His-tagged 4YSyn (unable to remove the His-tag) were dialyzed against water for 24-48 hrs with multiple water changes, lyophilized, and weighed. Endotoxin was removed by polymyxin B agarose beads following manufacturer's instructions (Sigma-Aldrich) and tested for residual endotoxin by Limulus amebocyte lysate (LAL) assay (E-Toxate, Sigma-Aldrich). Recombinant alpha-Syn-derived proteins were endotoxin-free as all batches of purified proteins utilized tested below the limit of detection for endotoxin by LAL (<0.05 endotoxin units, EU).
###end p 28
###begin p 29
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Lyophilized protein was resuspended (2 mg protein/ml) in 50 mM NaH2PO4 buffer containing 5 mM FeCl3 as a Lewis acid. Peroxynitrite (Upstate Biotechnology, Inc. Lake Placid, NY) was added dropwise to protein to achieve a 5 M excess while vigorously mixing the reaction mixture. Nitrated protein was dialyzed against water for 48 hrs using multiple water exchanges, lyophilized, and stored at -80degreesC.
###end p 29
###begin title 30
MALDI-TOF Mass Spectrometry
###end title 30
###begin p 31
MALDI-TOF mass spectrometric analysis was performed using a Voyager DE Pro mass analyzer (Applied Biosystems, Framingham, MA), which was externally calibrated prior to each assay. Data acquisition was performed using 500 laser shots. The MS scan range was set from 500 to 20,000 m/z. Saturated alpha-cyanohydroxycinnamic acid (Sigma-Aldrich) was used as matrix in these assays and samples were manually spotted onto MALDI targets.
###end p 31
###begin title 32
Enzyme-Linked Immunosorbent Assay (ELISA)
###end title 32
###begin p 33
###xml 893 894 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 895 896 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 908 909 868 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</italic>
###xml 1067 1068 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1070 1071 1026 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 321 327 <span type="species:ncbi:9913">bovine</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 703 714 <span type="species:ncbi:3704">horseradish</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 1378 1383 <span type="species:ncbi:10090">mouse</span>
Individual wells of Immunolon II ELISA plates (Thermo Electron Corp., Waltham, MA) were coated with 100 microl/well of native 4YSyn or N-4YSyn at 1 microg/ml PBS, pH 8.5. Plates were incubated for 2 hrs at 37degreesC and washed with 0.5% Tween20/PBS, pH 7.2 (PBS-T). Nonspecific binding was blocked by the addition of 1% bovine serum albumin in PBS, pH 7.2 (PBS-BSA) and incubation at 37degreesC for 1 hr. Plates were washed with PBS-T, 100 microl of 2-fold serial dilutions (from an initial 1:50 dilution in PBS-BSA) of serum samples from MPTP- or PBS-treated mice were added to each well, and incubated at 37degreesC for 1 hr. Plates were washed with PBS-T and 100 microl/well of a 1:5000 dilution of horseradish peroxidase (HRP)-conjugated anti-mouse IgG (SouthernBiotech, Birmingham, AL) was added. Plates were incubated at 37degreesC for 1 hr, washed with PBS-T, and reacted with 0.012% H2O2 and 2.2 mM o-phenylenediamine dihydrochloride (Sigma-Aldrich) in 100 microl of 0.1 M phosphate-citrate buffer, pH 5.0. The reaction was stopped with the addition of 2 N H2SO4, read at 490 nm on a microplate reader (Vmax Kinetic Microplate Reader, Molecular Devices Corporation, Sunnyvale, CA), and acquired data analyzed with interfacing SoftMax Pro software (Molecular Devices). Serum IgG concentrations were quantified from a standard curve prepared from known concentrations of mouse IgG (SouthernBiotech).
###end p 33
###begin title 34
Immunization and Immune Cell Adoptive Transfers
###end title 34
###begin p 35
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</sup>
###xml 130 156 126 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 181 182 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 872 873 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 887 888 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 899 900 891 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1194 1195 1186 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1299 1300 1291 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1376 1377 1368 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 107 110 <span type="species:ncbi:31658">CFA</span>
###xml 130 156 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 260 263 <span type="species:ncbi:31658">CFA</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 527 530 <span type="species:ncbi:31658">CFA</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1274 1278 <span type="species:ncbi:10090">mice</span>
###xml 1324 1328 <span type="species:ncbi:10090">mice</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
###xml 1435 1439 <span type="species:ncbi:10090">mice</span>
B10.BR (H-2K) mice were immunized with PBS, 50 microg of 4YSyn or N-4YSyn emulsified in an equal volume of CFA containing 1 mg/ml Mycobacterium tuberculosis (Sigma-Aldrich). B6 (H-2b) mice were immunized with PBS, 10 microg of 4YSyn or N-4YSyn with or without CFA. While immunization with adjuvant were administered subcutaneous (s.c.) on either side of the tail base, s.c. injections without adjuvant were given at 5 different sites. Fourteen days after primary immunization, mice were boosted with their respective antigens. CFA recipient mice were boosted with their respective antigens emulsified in IFA (Sigma-Aldrich). Five days following their final immunizations, donor mice were sacrificed and single cell suspensions were prepared from the spleen and draining lymph nodes after lysing red blood cells with ammonium chloride-potassium (ACK) lysis buffer (0.15M NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA, pH7.2). T cells were enriched by using the PAN T cell isolation kit (Miltenyi Biotec, Auburn, CA) and by depletion of magnetically labeled cells employing AutoMACS (Miltenyi Biotec). Twelve hrs post-MPTP intoxication, both B10.BR and B6 mice received intravenous (i.v.) injections of 5x107 spleen cells (SPC) in 0.25 ml of Hanks' balanced salt solution (HBSS). B10.BR mice also received 2.5x107 purified T cells. SCID mice were reconstituted with i.v. injections of 8x107 unfractionated SPC populations from WT B6 mice. RCS-SCID mice were rested for 4 wks prior to MPTP intoxication.
###end p 35
###begin title 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
3H-Thymidine in vitro Proliferation Assays
###end title 36
###begin p 37
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 744 745 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 333 339 <span type="species:ncbi:9913">bovine</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
Samples of pooled immunized donor cells used for adoptive transfer were tested for their proliferative capacity by 3H-thymidine incorporation after stimulation with either immunizing or irrelevant antigen. Donor SPC were plated at a density of 2x106 cells/ml complete RPMI tissue culture media [RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 1x nonessential aa, 55 microM 2-mercaptoethanol, 100 U/ml penicillin, and 100 microg/ml streptomycin (Mediatech Inc., Herndon, VA)]. SPC from PBS, 4YSyn, and N-4YSyn immunized mice were stimulated with 0, 1, 10, 50 microg/ml of immunizing antigen, 4YSyn or N-4YSyn, and cultured at 37degreesC for 5 days. Cells were pulsed with 1 microCi 3H-thymidine/well for the final 18 hrs of culture, harvested onto glass fiber plates, and counted by beta-scintillation spectrometry (TopCount, Packard-PerkinElmer Instruments, Wellesley, MA).
###end p 37
###begin title 38
Western Blot Analysis
###end title 38
###begin p 39
###xml 231 237 <span type="species:ncbi:9986">rabbit</span>
###xml 288 291 <span type="species:ncbi:10116">rat</span>
###xml 354 364 <span type="species:ncbi:10141">guinea pig</span>
Ventral midbrain (VMB) and lymphoid organ protein extracts (80 microg/lane) were separated by 16% SDS-PAGE (Invitrogen) and transferred for 45 min onto 0.2 microm PVDF membranes (Millipore, Bedford, MA). Membranes were probed with rabbit antibodies to NT (1:2000; Chemicon) or monoclonal rat antibodies to myelin basic protein (MBP, 1:1000, Chemicon) or guinea pig antibodies to alpha-Syn (1:1000; Ab-1, Oncogene/EMD Biosciences). Appropriate HRP-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) were used to visualize blots using SuperSignal West Pico Chemiluminescent substrate and CCL-XPosure film (Pierce Biotechnology, Inc., Rockford, IL). Immunoblots were stripped and reprobed with antibodies to alpha-actin (1:5000; Chemicon,) as an internal control.
###end p 39
###begin title 40
Identification of alpha-Syn in MPTP-CLN
###end title 40
###begin p 41
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Anti-N-alpha/beta-syn (clone nSyn12, mouse ascites, Upstate) that specifically recognizes N-alpha-Syn (14.5 kD) and N-beta-Syn (17 kD) but not non-nitrated alpha/beta-Syn was used for immunoprecipitation (IP). VMB and CLN from PBS or MPTP treated mice were dissected out, homogenized in ice-cold RIPA buffer, pH 7.4 and centrifuged at 10,000xg for 10 min at 4degreesC to remove cellular debris. Protein A/G PLUS-Agarose beads (Santa Cruz Biotechnology) were added to 2 mg total cellular protein, incubated for 1 hr at 4degreesC. Beads were centrifuged at 1,000xg for 5 min at 4degreesC. The supernatant was incubated with 40 microl anti-N-alpha-Syn overnight at 4degreesC on a rotating device, and then with Protein A/G PLUS-Agarose beads for 1 hr on a rotating device at 4degreesC. Immunoprecipitates were collected after centrifugation at 1,000xg for 5 min at 4degreesC, washed once with RIPA buffer and twice with PBS, resuspended in 40 microl of 1x electrophoresis sample buffer.
###end p 41
###begin p 42
###xml 657 658 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 660 661 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 723 724 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 726 727 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1622 1626 1604 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Ciborowski1">[38]</xref>
###xml 1628 1632 1610 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Enose1">[39]</xref>
###xml 1634 1638 1616 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-RicardoDukelow1">[40]</xref>
###xml 1640 1644 1622 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Ciborowski2">[41]</xref>
###xml 1646 1650 1628 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Glanzer1">[42]</xref>
###xml 1652 1656 1634 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Kadiu1">[43]</xref>
N-alpha-Syn IP samples were fractionated by large format 16% Tricine SDS-PAGE (Jule Inc., Milford, CT; BIORAD Laboratories, Inc, Los Angeles, CA) at constant voltage for 8-10 hrs. The gel was stained with highly sensitive SYPRO Ruby stain (Invitrogen) and scanned at excitation (400 nm) and emission (630 nm) wavelengths using Typhoon scanner (Amersham Biosciences, Piscataway, NJ) to visualize the protein bands. Small gel fragments (3-4 mm) corresponding to molecular weight (12-18 kD) were excised from each lane of the same gel stained with Coomassie. In brief, gel pieces were destained for 1 hr at room temperature using 100 microl of 50% ACN/50 mM NH4CO3. Gel pieces were dried and incubated with trypsin in 10 mM NH4CO3 (Promega, Madison, WI) overnight at 37degreesC. Peptides were extracted by washing gel pieces twice with 0.1% TFA and 60% ACN. Dried samples were resuspended in 12 microl of 0.1% formic acid in water for automated injection. All samples were purified using ZipTip (Millipore) prior to MS analysis. In-gel trypsin digested proteins were fractionated on microcapillary RP-C18 (Ciborowski et al., 2004). The resulting peptides were sequenced using Electrospray Ionization (ESI)-LC MS/MS (Proteome X System with LCQDecaPlus mass spectrometer, thermoElectron, Inc., San Jose, CA) with a nanospray configuration. The spectra obtained from LC-MS/MS analysis were searched against the NCBI.fasta rodent protein database using SEQUEST search engine (BioWorks 3.2 SR software from ThermoElectron, Inc, San Jose, CA.). Criteria for high confidence protein identification were used as previously published [38], [39], [40], [41], [42], [43].
###end p 42
###begin title 43
Flow Cytometry
###end title 43
###begin p 44
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 418 423 <span type="species:ncbi:10090">mouse</span>
Single cell suspensions were prepared from deep CLN from C57BL/6 mice 20-24 hrs post PBS or MPTP (18 mg/kg) intoxication. Cell suspensions were analyzed for cell surface expression of CD11c, CD11b, and MHC class II (I-Ab). Also, prior to adoptive transfers, cell populations from immunized donors were stained for T cells using PE conjugated anti-mouse CD3epsilon (BD Pharmingen) and B cells with FITC conjugated anti-mouse CD19 (BD Pharmingen). Analysis was performed with a FACSCalibur flow cytometer interfaced with CellQuest software (BD-Biosciences, Immunocytometry Systems, San Jose, CA).
###end p 44
###begin title 45
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Determination of N-4YSyn-mediated Toxicity In Vitro
###end title 45
###begin p 46
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 388 389 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
For proliferation analyses, purified T cells from naive B6 mice were plated with SPC irradiated at 3000 rad (1:3) at 2x106 cells/ml in complete RPMI tissue culture media and activated with anti-CD3 (0.5 microg/ml, 145-2C11; BD Pharmingen) in U-bottom 96-well tissue culture plates. Graded concentrations of 4YSyn or N-4YSyn were added to quadruplicate wells. After activation for 3 days, 3H-thymidine incorporation was performed as described previously.
###end p 46
###begin p 47
###xml 123 124 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 307 308 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To assess alpha-Syn-mediated cytotoxicity, purified T cells were stimulated with anti-CD3 and cultured at a density of 1x106 cells/ml for 24 hrs in media alone or in the presence of 4YSyn or N-4YSyn at concentrations of 1, 3, 10, or 30 microg/ml. Cells were stained with PI, washed and the percentages of PI+ dead cells and MFI were analyzed by flow cytometry.
###end p 47
###begin title 48
Macrophage and MES 23.5 Cultures
###end title 48
###begin p 49
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 582 583 578 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 893 894 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1150 1151 1136 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
BMM were prepared from C57BL/6 adult male (6-12 weeks old) mice. The animals were sacrificed by CO2 asphyxiation. Single cell suspensions of bone marrow cells were obtained from femur bone marrow cavities after flushing with HBSS, and red blood cells lysed with ACK buffer. The bone marrow cells were cultured in complete DMEM medium (Dulbecco's Modified Eagles Media supplemented with 10% FBS, 2 mM L-glutamine, and 1% penicillin/streptomycin) containing 2 microg/ml macrophage colony stimulating factor (MCSF), a generous gift from Wyeth Pharmaceuticals (Cambridge, MA) in a 5% CO2/37degreesC incubator. Non-adherent cells were removed from flasks at 1, 4, and 7 days by successive DMEM washes. Adherent BMM were harvested and replated for experiments following 7-14 days of culture. Cells from the MES 23.5 dopaminergic cell line kindly provided by Dr. Stanley Appel, were cultured in 75-cm2 flasks in DMEM/F12 with 15 mM HEPES (Invitrogen) containing N2 supplement (Invitrogen), 100 U/ml of penicillin, 100 microg/ml streptomycin, and 5% FBS. Cells were grown to 80% confluence then co-cultured with BMM in serum free MEM/F12 at a density of 1x105 cells (1:1) on sterile glass coverslips.
###end p 49
###begin title 50
N-alpha-Syn SPC-Induced Microglia Cytotoxicity
###end title 50
###begin p 51
###xml 98 106 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
SPC isolated from N-4YSyn (10 microg) immunized B6 mice were cultured in RPMI media and activated in vitro for 4 days with N-4YSyn (1 microg/ml). MES 23.5 cells or macrophages alone or MES 23.5 and macrophage co-cultures were stimulated with aggregated N-alpha-Syn (1.45 microg/ml) alone and in combination with either activated SPC or supernatants obtained from activated SPC for 24 hrs. Unstimulated cultures served as controls. Assays for viable and dead cells were performed with Live/Dead Viability/Cytotoxicity kit (Invitrogen) according to the manufacturer's protocol and viewed under a fluorescence microscope (Nikon Eclipse E800, Buffalo Grove, IL). Images were captured at 100x magnification and quantification of live (green) and dead (red) counts was performed from 4-8 different fields.
###end p 51
###begin title 52
Cytokine array
###end title 52
###begin p 53
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 372 377 <span type="species:ncbi:10090">Mouse</span>
Triplicate co-cultures of antigen presenting cells (APC) and T cells from PBS-, 4YSyn- and N-4YSyn-immunized mice were stimulated with 4YSyn or N-4YSyn. After 24 hours of culture, 50 microl samples were collected, centrifuged, and supernatants frozen at -80degreesC until utilized. Frozen supernatants were thawed only once and analyzed using the BD Cytometric Bead Array Mouse Th1/Th2 Kit (BD Biosciences, San Jose, CA) according to the manufacturer's instructions.
###end p 53
###begin title 54
Statistical Analysis
###end title 54
###begin p 55
###xml 113 114 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All values are expressed as mean+/-SEM. Differences among normally distributed means were evaluated by Student's t test for two group comparisons or one-way ANOVA followed by Bonferroni post-hoc tests for pairwise comparisons amongst multiple data sets (Statistica v7, Statsoft, Tulsa, OK, and SPSS v13, SPSS, Inc., Chicago, IL) and were considered significant at p </= 0.05 unless otherwise indicated. Kolmogorov-Smirnov (K-S) analysis was performed for flow cytometric data analysis.
###end p 55
###begin title 56
Results
###end title 56
###begin title 57
CNS Antigens Drain to CLN Following MPTP Intoxication
###end title 57
###begin p 58
###xml 349 358 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1A</xref>
###xml 622 626 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Shin1">[44]</xref>
###xml 867 876 843 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1B</xref>
###xml 1195 1198 1159 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Weinreb1">[6]</xref>
###xml 1200 1204 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hodara1">[14]</xref>
###xml 1206 1210 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Dufty1">[45]</xref>
###xml 1212 1216 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hasegawa1">[46]</xref>
###xml 1218 1222 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-ElAgnaf1">[47]</xref>
###xml 1305 1314 1265 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1C</xref>
###xml 1417 1424 1377 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t001">Table 1</xref>
###xml 1486 1493 1442 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t001">Table 1</xref>
###xml 1765 1774 1705 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1D</xref>
###xml 2008 2017 1944 1953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1D</xref>
###xml 2528 2529 2464 2465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2535 2544 2471 2480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1E</xref>
###xml 2577 2578 2513 2514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2591 2592 2527 2528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3044 3053 2968 2977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g001">Figure 1F</xref>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 1359 1363 <span type="species:ncbi:10090">mice</span>
###xml 1411 1415 <span type="species:ncbi:10090">mice</span>
###xml 1555 1561 <span type="species:ncbi:9986">rabbit</span>
###xml 2114 2118 <span type="species:ncbi:10090">mice</span>
###xml 2609 2613 <span type="species:ncbi:10090">mice</span>
###xml 2828 2832 <span type="species:ncbi:10090">mice</span>
###xml 2993 2997 <span type="species:ncbi:10090">mice</span>
To determine if CNS antigens drain to CLN during established neurodegeneration of the nigrostriatal pathway, their presence in ventral midbrain (VMB), cervical, axillary, inguinal, mesenteric lymph nodes and spleens were determined 24 hrs after MPTP-intoxication in C57BL6 mice. The presence of unmodified alpha-Syn was demonstrated in VMB and CLN (Figure 1A) as well as other lymph nodes and in the spleen from phosphate-buffered (PBS)- or MPTP-treated mice in anti-alpha-Syn-probed immunoblots (data not shown). These findings also confirmed the expression of unmodified alpha-Syn amongst cells of hematopoietic lineage [44]. N-alpha-Syn IP showed that N-alpha-Syn was present in the CLN of MPTP-treated, but not PBS-treated mice as similar molecular weight bands were observed from gels probed with SYPRO Red and Western blots performed with alpha-Syn antibodies (Figure 1B). To validate the presence of NT-modified alpha-Syn after MPTP treatment, N-alpha-Syn immunoprecipitates were obtained after in-gel tryptic digestion of 12-18 kD fragments acquired from the VMB and CLN and sequenced by LC-MS/MS. This regions was chosen as it represents the molecular mass ranges of oxidized alpha-Syn [6], [14], [45], [46], [47]. Sequence analysis demonstrated alpha-Syn peptides (yellow highlighted sequences, Figure 1C) in the VMB from both PBS- and MPTP-treated mice but exclusively in the CLN of MPTP-intoxicated mice (Table 1). alpha-Syn peptides were identified at >99.999% confidence (Table 1). Western blot analysis of lymphoid tissue homogenates using rabbit NT antibodies detected a single band with a molecular mass of approximately16-18 kD-which is comparable to that of alpha-Syn-in CLN from MPTP-intoxicated animals, but not in other lymph nodes or spleen (Figure 1D, blots of mesenteric lymph nodes and spleen are not shown). These results were confirmatory for the presence of N-alpha-Syn in the draining CLN. Another CNS antigen, MBP was also detected only in the CLN of MPTP intoxicated animals (Figure 1D). NT-modified proteins and MBP were absent in lymph nodes and spleens of control (PBS-injected) mice. These data suggest that brain proteins released as a consequence of nigrostriatal injury, drain to the deep CLN, placing them in organs associated with efficient presentation of antigen. To demonstrate the functional significance of these observations, single cell suspensions were prepared from CLN isolated from MPTP animals and controls, and analyzed by flow cytometry for MHC class II expression on CD11b+ APC (Figure 1E). Increased frequencies of CD11b+/MHC class II+ in MPTP-treated mice compared to PBS controls was taken as evidence of leukocyte activation in the deep CLN following MPTP-induced nigrostriatal injury. Supporting the induction of a alpha-Syn specific immune response, sera from WT B6 mice 21 days after chronic MPTP intoxication were analyzed for anti-alpha-Syn IgG and compared to animals that received PBS. Serum levels of alpha-Syn antibodies in mice exposed to MPTP were significantly increased (Figure 1F). Together, these results demonstrate that NT-modified alpha-Syn draining into the deep CLN is capable of eliciting a peripheral immune response.
###end p 58
###begin title 59
Drainage of N-alpha-Syn and MBP to CLN with macrophage activation and production of alpha-Syn serum antibodies after MPTP intoxication.
###end title 59
###begin p 60
###xml 1007 1008 981 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1072 1073 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1076 1077 1050 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1603 1604 1563 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 738 743 <span type="species:ncbi:10090">mouse</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 1156 1160 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
(A) Western blot of tissue homogenates from VMB and CLN of mice 20 hrs following treatment with PBS or MPTP, were probed with antibodies to alpha-Syn. (B) N-alpha/beta Syn IP with (clone nSyn12 antibodies) against CLN homogenates from PBS or MPTP-treated mice. Immunoprecipitates were fractionated on a 16% polyacrylamide gel and the gel stained with SYPRO Red or blotted. The Western blot was probed with anti-alpha-Syn. (C) Proteins recovered from in-gel digestion of 12-18 kD fragments from anti-N-alpha/beta Syn of CLN immunoprecipitates were were identified by LC-MS/MS. The sequence coverage by peptides identified by LC-MS/MS from the CLN of MPTP-treated mice is highlighted in yellow within the primary aa sequence of full-length mouse alpha-Syn. (D) Western blots of lymph node homogenates (Cervical, Axillary, and Inquinal) from mice treated with PBS or MPTP. Blots were probed with antibodies to nitrotyrosine (NT) or anti-myelin basic protein (MBP). (E) Flow cytometric analysis of CD11b and I-Ab expression in cells from CLN, show an increased number of CD11b+I-A+ cells 24 hrs after MPTP treatment compared to PBS administered animals (n = 3 mice/group). (F) Antibodies against alpha-Syn and N-alpha-Syn in sera of B6 WT mice on day 21 following MPTP intoxication (n = 8) or PBS control treatment (n = 5) as determined by anti-alpha-Syn specific ELISA. Sera from MPTP treated group contained significantly higher IgG antibodies directed against 4YSyn (p = 0.021) and N-4YSyn (p = 0.016) compared to PBS treated control sera. Comparisons of mean IgG concentrations +/- SEM was by Student's t test.
###end p 60
###begin title 61
###xml 191 195 <span type="species:ncbi:10090">mice</span>
Probabilities (p values) of protein sequence matches within 12-18 kD bands from anti-N-alpha/beta-synuclein immunoprecipitation and LC MS-MS analyses of VMB and CLN from PBS- or MPTP-treated mice.
###end title 61
###begin title 62
Adaptive Immunity Participates in MPTP-Nigral Degeneration
###end title 62
###begin p 63
###xml 475 476 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 734 743 730 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2A</xref>
###xml 776 777 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 892 901 888 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2B</xref>
###xml 950 951 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1040 1049 1036 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2B</xref>
###xml 1154 1155 1150 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1197 1213 1193 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2A and 2B</xref>
###xml 1299 1300 1295 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1322 1331 1318 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2A</xref>
###xml 1404 1405 1400 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1479 1488 1475 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2A</xref>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">Mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
###xml 1259 1263 <span type="species:ncbi:10090">mice</span>
###xml 1464 1469 <span type="species:ncbi:10090">mouse</span>
The presence of NT modifications of alpha-Syn in draining lymphatic tissue following MPTP-induced nigrostriatal injury, along with evidence of lymphoid-associated APC activation provided support for antigen presentation to T cells and subsequent immune responsiveness. To substantiate this idea, we explored whether an endogenous adaptive immune system was required for MPTP-induced nigrostriatal degeneration. B6 WT mice, B6 SCID mice, and B6 SCID mice reconstituted with 108 B6 WT splenocytes (SPC) (RCS-SCID) were treated with PBS or a chronic MPTP regimen. Mice were sacrificed at 21 days after the last MPTP injection, and VMB sections immunostained for tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis (Figure 2A, left panels). The numbers of TH+ neurons in the SN showed a 33% reduction in WT B6 animals that received MPTP compared to those that received PBS (Figure 2B). No significant difference in the numbers of TH+ neurons was observed in MPTP-treated SCID mice compared to SCID mice that received PBS (Figure 2B). In contrast, immune reconstituted SCID mice (RCS-SCID) treated with MPTP showed significantly fewer TH+ neurons compared to the SCID MPTP group (Figure 2A and 2B). To validate the reconstitution of RCS-SCID mice, spleens were immunostained for CD3+ T cell distribution (Figure 2A, right panels). T cell repopulation was confirmed by the presence of CD3+ T cells in the periarteriolar lymphoid sheath of RCS-SCID mouse spleens (Figure 2A),
###end p 63
###begin p 64
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 300 309 300 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2C</xref>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 452 443 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g002">Figure 2C</xref>
###xml 571 572 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 702 703 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
VMB and cerebellum control sections of WT, SCID, and RCS-SCID mice treated with MPTP were immunostained for T cells using antibodies against CD3, CD4, and CD8. CD3 immunostaining of MPTP-treated B6 mice demonstrated CD3+ cells in the VMB beginning at day 0, present at day 4 after MPTP intoxication (Figure 2C) that persisted to day 14. Both CD4+ and CD8+ subpopulations were also present in VMB of only MPTP-treated animals at 4 and 14 days (Figure 2C). No T cell accumulation was observed in PBS or MPTP-treated SCID mice at any time point (data not shown), whereas CD3+ T cell accumulations in VMB of RCS-SCID mice after MPTP-treatment were identified. Cerebellar tissue of MPTP animals had </=1 CD3+ T cell per high power field examined present suggesting specific cell entry into affected regions. Taken together, these data support the occurrence of an adaptive immune response triggered by modified CNS antigens that modulates the vulnerability of the dopaminergic neurons to MPTP through the migration of T cells into the CNS.
###end p 64
###begin title 65
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Nigral degeneration following MPTP-intoxication in B6 SCID mice before and after lymphoid cell reconstitution.
###end title 65
###begin p 66
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 652 643 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">abcdefg</sup>
###xml 703 706 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acd</sup>
###xml 706 707 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 716 719 714 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bef</sup>
###xml 719 720 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 728 729 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</sup>
###xml 729 730 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
(A) Photomicrographs of TH-immunostained SN (left panels) and CD3-immunostained spleen sections (right panels) from B6 (WT), SCID, and reconstituted SCID (RCS-SCID) mice treated with PBS or MPTP and obtained on day 21 post-MPTP intoxication. Immunostaining for expression of CD3 in spleens show normal distributions of CD3+ T cells in B6 WT and RCS-SCID mice treated with PBS or MPTP. Note the absence of CD3+ T cells in spleens from SCID MPTP mice. (B) Quantification of TH+ neurons in the SN of B6 WT, SCID, or reconstituted (RCS) SCID mice treated with PBS or MPTP. Values represent mean number of TH+ neurons +/- SEM for 5-9 mice per group. abcdefgPair-wise comparisons by Bonferroni post-hoc test: acdp<0.0001, befp<0.001, gp<0.05. (C) Coronal VMB sections of MPTP intoxicated B6 mice reacted with antibodies against CD3, CD4 and CD8 show positive immunostaining of cells with small, round lymphocytic morphology (magnification = 400X).
###end p 66
###begin title 67
###xml 14 19 <span type="species:ncbi:10090">Mouse</span>
Prediction of Mouse N-alpha-Syn Specific T Cell Epitopes
###end title 67
###begin p 68
###xml 194 198 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Peters1">[48]</xref>
###xml 233 234 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 242 243 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 249 256 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t002">Table 2</xref>
###xml 421 428 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t002">Table 2</xref>
###xml 444 445 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 827 828 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 892 893 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 902 903 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1321 1322 1289 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 1341 1342 1309 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1354 1361 1322 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t002">Table 2</xref>
###xml 1421 1422 1389 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 1433 1434 1401 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1618 1619 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1972 1973 1932 1933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2104 2105 2060 2061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2327 2328 2275 2276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2335 2336 2283 2284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2426 2427 2374 2375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2457 2458 2405 2406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2464 2465 2412 2413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 207 213 <span type="species:ncbi:10090">murine</span>
###xml 296 301 <span type="species:ncbi:10090">mouse</span>
###xml 1435 1439 <span type="species:ncbi:10090">mice</span>
###xml 2053 2057 <span type="species:ncbi:10090">mice</span>
###xml 2439 2443 <span type="species:ncbi:10090">mice</span>
To test the probability of N-alpha-Syn induced adaptive immune responses, we compared the numbers of predicted alpha-Syn specific T cell epitopes with the propensity to bind class I MHC grooves [48] for the murine MHC haplotypes, H-2k and H-2b (see Table 2). However, since the last 40 aa of the mouse alpha-Syn contains 4 Tyr residues available for nitration, our analysis focused on this C-terminal alpha-Syn fragment. Table 2 shows that H-2Kk epitopes have a superior ability to bind with high and intermediate affinity alpha-Syn-derived 8-11-meric peptide fragments derived from the whole alpha-Syn molecule or from its C-terminal 38-meric fragment. These data demonstrate significant T cell induction potential. In fact, alpha-Syn has 100 potential T cell epitopes, 73 of which contain Tyr that were predicted to bind H-2Kk molecules, while only 8 and 15 potential epitopes may bind H-2Db and H-2Kb molecules, respectively. This was also for nitrated epitopes containing Tyr residue including those with a Tyr residue within the central region of the epitope that presents prominently to the T cell receptor. These epitopes do not contain anchor aa that mediate binding to the MHC groove. Dramatic difference in the number of Tyr-containing T cell epitopes from C-terminal segment of alpha-Syn predicted to bind H-2Kk but not any of H-2b molecules (Table 2, data in brackets) suggests a potential preference for H-2Kk versus H-2b mice to induce T cell responses to nitrated C-terminal fragments of alpha-Syn. These fragments, if facing T cell receptors, have greater chances of inducing MHC class I-restricted CD8+ T cells due to lack of negative selection against N-alpha-Syn epitopes in the embryonic thymus. Further epitope prediction analysis revealed a number of 15-meric epitopes, including Tyr-containing peptides from C-terminal, that can bind with increased affinity class II MHC groove, thus increasing the propensity of inducing MHC class II-restricted CD4+ T cells specific for Tyr-containing alpha-Syn C-terminal fragments. Therefore, mice expressing MHC class I and II molecules of H-2k haplotypes are capable of generating immune responses to NT-modified alpha-Syn. Interestingly, that alpha-Syn C-terminal fragment contains several Tyr-containing peptides with predicted significant binding affinity for IAk and IAb MHC molecules (18 and 14 epitopes, respectively) suggests a significant potential for CD4+ T cells of mice expressing IAk or IAb to respond to nitrated epitopes from alpha-Syn C-terminal.
###end p 68
###begin title 69
Numbers of putative alpha-Syn epitopes for presentation to T cell receptors predicted from the binding potential of MHC class I and II molecules for the aa sequence of alpha-Syn.
###end title 69
###begin p 70
###xml 102 103 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 534 535 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 602 604 598 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 822 826 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Guan1">[86]</xref>
###xml 828 832 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Guan2">[87]</xref>
Number of predicted T-cell epitopes from the 38-mer C-terminal fragment of alpha-Syn are in brackets. aFor class I MHC binders three following grades for scoring included: low immunogenic epitopes, scores <-3; mild immunogenic epitopes, scores >-3 but <-2; high immunogenic, scores >-2; all computations were done using the Immune Epitope Database and Analysis Resource (IEDB) () and integrative epitope prediction tool [proteasomes cleavage, Transporter associated with Antigen Processing (TAP) binding, processing and MHC binding]. bFor class II MHC binders, scoring grades were based on predicted IC50 values and were: low (1000 nM-5000 nM), intermediate (200-1000 nM) and high (<200 nM) for groove binding prediction by MHCPred. This prediction algorithm considers peptides with predicted IC50 >5000 nM as non-binders [86], [87].
###end p 70
###begin title 71
Purification and Nitration of Recombinant alpha-Syn
###end title 71
###begin p 72
###xml 526 533 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 743 750 732 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 848 857 837 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3B</xref>
###xml 947 956 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3C</xref>
###xml 1255 1264 1240 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3C</xref>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 526 533 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 743 750 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1220 1225 <span type="species:ncbi:10090">mouse</span>
Based on our findings, we hypothesized that in PD, NT modifications of alpha-Syn could be a key step converting the endogenous protein to an immunogen. Here, we used the C-terminal 40 aa alpha-Syn fragment (4YSyn) as it contains all four tyrosine residues that are nitrated, thus limiting the possible specificities of epitopes capable of generating an immune response. For this, the mouse cDNA encoding the final 40 aa was cloned into the bacterial pET-28a His-tag expression vector and recombinant protein expressed in BL21 E. coli following isopropyl-beta-D-thiogalactopyranoside (IPTG) induction. Expression of the recombinant protein exhibited no apparent toxicity to the bacterial expression system. Affinity-purified 4YSyn peptide from E. coli lysates was detected as a prominent single band using silver staining on 12% polyacrylamide gel (Figure 3B) and by Western blot using a polyclonal antibody raised against aa 120-140 of alpha-Syn (Figure 3C). Reverse-phase high performance liquid chromatography (RP-HPLC) analysis of isolated 4YSyn products demonstrated purities equal to or in excess of 97%. NT modifications of 4YSyn peptide (N-4YSyn) after peroxynitrite nitration was confirmed by Western blot using mouse monoclonal anti-NT antibody (Figure 3C).
###end p 72
###begin p 73
###xml 115 124 115 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3B</xref>
###xml 141 150 141 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3C</xref>
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3D</xref>
###xml 431 440 427 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3D</xref>
###xml 445 452 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t003">Table 3</xref>
###xml 1172 1188 1168 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3A and 3D</xref>
Homogeneity of purified 4YSyn and its modified forms (aggregated and nitrated) was assessed based on: 1D SDS-PAGE (Figure 3B), Western blot (Figure 3C), and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Figure 3D). The predominant peak for 4YSyn by MALDI-TOF analysis was 6592 m/z, which corresponded to the 6718 expected mass of purified recombinant alpha-Syn within <2% mass accuracy (Figure 3D and Table 3). To provide proof that the mass discrepancy originated from recombination errors within the His-tag region obtained during protein purification, but not within the biologically active portion of the molecule, we digested the recombinant 4YSyn protein with trypsin and measured masses of resulting fragments using MALDI-TOF. The observed masses of the generated fragments were Arg-cleaved 4YSyn and Lys-cleaved 4YSyn. These corresponded to the expected masses with 0.07% of mass accuracy. Next, we compared the mass of native 4YSyn to N-4YSyn. The oxidized peptide or its trypsin cleaved fragments revealed a 184 D mass increase that is analogous to the expected mass of 4 nitro groups corresponding to 4 NT- residues (Figure 3A and 3D). Based on these observations, we concluded that reaction of 4YSyn with peroxynitrite, under the conditions used in this study, efficiently nitrated all four available Tyr residues in 4YSyn.
###end p 73
###begin title 74
Characterization of purified and nitrated recombinant 4YSyn.
###end title 74
###begin p 75
###xml 126 133 126 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100&#8211;140</sub>
(A) Primary aa sequence of His-tagged 4YSyn peptide. The His-Tag sequence is highlighted in yellow. The sequence of 4YSyn (Syn100-140) is shown underlined with 4 Tyr residues (magenta) as potent sites for nitration. Trypsin cleavage sites at Arg (arrowhead) and Lys (arrow) are shown. (B) Purified 4YSyn (lane 1) and N-4YSyn following nitration with peroxynitrite (lane 2) fractionated on a 10-20% polyacrylamide gel and visualized using silver stain. Covalently cross-linked oligomers are indicated by arrowheads. (C) Western blot confirmation of purified 4YSyn and its associated NT modifications following peroxynitrite treatment. (D) MALDI-TOF spectra of purified 4YSyn (top panel), N-4YSyn (middle panel), and 4YSyn after tryptic digest (lower panel).
###end p 75
###begin title 76
Theoretical and Observed Masses of 4YSyn, N-4YSyn and Tryptic Digest Fragments.
###end title 76
###begin title 77
###xml 52 56 <span type="species:ncbi:10090">Mice</span>
N-4YSyn Induces Specific Immune Responses in B10.BR Mice
###end title 77
###begin p 78
###xml 71 72 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 175 184 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g004">Figure 4A</xref>
###xml 622 631 618 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g004">Figure 4B</xref>
###xml 752 760 748 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 169 172 <span type="species:ncbi:31658">CFA</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
To test our predictions of immune responses to N-alpha-Syn, B10.BR (H-2k) mice were immunized with N-4YSyn, 4YSyn, or PBS each emulsified in complete Freund's adjuvant (CFA) (Figure 4A). Fourteen days following the initial immunization, mice were boosted with their respective immunogens emulsified in incomplete Freund's adjuvant (IFA). Five days later, mice were sacrificed and SPC were tested for antigen-specific T cell proliferative responses to N-4YSyn or 4YSyn. Stimulation with 4YSyn yielded no significant immune responses regardless of whether mice were immunized with adjuvant containing PBS, 4YSyn or N-4YSyn (Figure 4B). In contrast, significant proliferative responses were afforded from SPC of mice immunized with N-4YSyn and challenged in vitro with N-4YSyn, but not 4YSyn. Moreover, N-4YSyn stimulated SPC from mice immunized with adjuvant containing 4YSyn or PBS failed to induce significant proliferative responses. These data indicate that immunization with N-4YSyn, but not 4YSyn is capable of inducing antigen specific immune responses to NT-modified CNS antigens.
###end p 78
###begin title 79
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Experimental protocol for adoptive transfer and lymphocyte proliferation assessment of donor SPC in B10.BR mice.
###end title 79
###begin p 80
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</sup>
###xml 415 416 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 443 444 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 952 953 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 100 103 <span type="species:ncbi:31658">CFA</span>
###xml 105 109 <span type="species:ncbi:10090">Mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
(A) B10.BR (H-2K) mice were immunized with PBS, 50 microg 4YSyn, or 50 microg N-4YSyn emulsified in CFA. Mice were boosted 14 days later with PBS or their respective antigens in IFA. After 5 days, donor mice were sacrificed and single cell suspensions were prepared from the draining inguinal lymph nodes and spleen, and T cells were enriched by negative selection. Twelve hours after the final MPTP injection, 5x107 donor immune SPC or 2.5x107 T cells were adoptively transferred to MPTP-treated recipient mice. SPC were evaluated for antigen specificity prior to adoptive transfer by lymphocyte proliferation assays. SN of recipients were evaluated after 28 days of MPTP treatment for migration of T cells, survival of dopaminergic neurons, and reactive microglia. (B). SPC were tested for antigen specific proliferation by culturing in the presence of media alone or media containing 3 microg/ml of immunizing antigens for 5 days and using standard 3H-thymidine incorporation assays.
###end p 80
###begin title 81
Adoptive Transfer of N-4YSyn SPC and T Cells Exacerbates MPTP-induced Microglial Activation and Dopaminergic Neuronal Death
###end title 81
###begin p 82
###xml 341 350 333 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g004">Figure 4A</xref>
###xml 382 383 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 573 574 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 773 774 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 784 793 776 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g005">Figure 5A</xref>
###xml 901 902 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 965 974 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g005">Figure 5B</xref>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
In light of the fact that modified alpha-Syn is capable of evading tolerance and inducing reactive T cells, we next tested whether modified alpha-Syn-activated T cells could exacerbate MPTP-induced dopaminergic neurodegeneration. The experimental scheme for adoptive transfer of SPC or purified T cells from immunized animals is outlined in Figure 4A. For these studies, B10.BR (H-2k) donor mice were immunized and boosted with N-4YSyn or 4YSyn, and SPC were adoptively transferred to MPTP-treated syngeneic recipients. To delineate effects due specifically to T cells, CD3+ T cells were enriched by negative selection and transferred to an additional group of MPTP-treated animals. Flow cytometric analysis showed that the enriched population from N-4YSyn mice was 94% CD3+ T cells (Figure 5A). Adoptive transfer of purified T cells from N-4YSyn immunized donors to MPTP intoxicated mice revealed CD3+ T cell infiltrates in the SNpc on day 2 after MPTP treatment (Figure 5B).
###end p 82
###begin title 83
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Adoptive transfer of SPC and purified T cells from N-4YSyn vaccinated B10.BR donors leads to infiltration of T cells in the SNpc of MPTP mice on day 2.
###end title 83
###begin p 84
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
(A) Frequency of CD3+ T cells and CD19+ B cells before and after enrichment of T cells. Population of enriched T-cells was 94% CD3+ prior to adoptive transfer to B10.BR mice. (B) Sections throughout the SNpc were immunostained for CD3 and counterstained with thionin. Clusters of CD3+ cells are observed within the SNpc (arrowheads) as seen at 100x magnification (left). Magnification (600X) of boxed area (left panel) is shown (right panel). CD3+ cells are small and round exhibiting lymphocyte morphology.
###end p 84
###begin p 85
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g006">Figure 6</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-JacksonLewis1">[49]</xref>
###xml 933 941 933 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g006">Figure 6</xref>
###xml 1193 1201 1193 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g006">Figure 6</xref>
###xml 1232 1233 1232 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1341 1343 1339 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1451 1452 1445 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1480 1481 1472 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1504 1505 1494 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1569 1570 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1277 1281 <span type="species:ncbi:10090">mice</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
###xml 1571 1575 <span type="species:ncbi:10090">mice</span>
MPTP treated mice showed fluorescent neurons within the SN using the degenerating cell marker Fluoro-Jade C by day 2, but not by day 7 (Figure 6, left and middle panels) confirming previous kinetic data regarding MPTP-induced nigral neuronal death obtained by silver staining techniques [49]. MPTP treated mice that received immune cells from N-4YSyn immune mice showed more Fluoro-Jade C stained neurons within the SN by day 2 than MPTP-intoxication alone, and, in contrast to the latter, Fluoro-Jade C stained neurons within the SN by day 7 as well. In the PBS control group, no Fluoro-Jade C stained neurons were observed at any time point. Following MPTP administration, microgliosis is striking and immediate. Our initial time course studies are in line with these findings and show that the microgliosis and dopaminergic neurodegeneration in B10.BR mice are virtually resolved respectively by days 4 and 7 post-MPTP injection (Figure 6, right and middle panels, respectively). However, adoptive transfer of SPC from B10.BR mice, regardless of immunization protocol, was associated with a persistent microglial response, as evidenced by quantitative morphology with Mac-1 immunostaining (Figure 6, right panel). Counts of Mac-1+ microglia were greatest (p<0.0001) in MPTP mice treated with SPC from N-4YSyn immunized mice [84.1+/-7.0/mm2 (mean+/-SEM)] compared to those from mice treated with MPTP and SPC from 4YSyn immunized mice (26.9+/-3.5/mm2), MPTP alone (27.7+/-3.2/mm2), or PBS (0.7+/-0.3/mm2). These data suggest that the adaptive immune components of H-2k mice following MPTP administration contribute to the neuroinflammatory phenotype seen in these animals.
###end p 85
###begin title 86
###xml 34 38 <span type="species:ncbi:10090">mice</span>
SPC from N-4YSyn immunized B10.BR mice exacerbate MPTP-induced dopaminergic neurodegeneration and induce microglial responses in the SNpc.
###end title 86
###begin p 87
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
Photomicrographs from VMB sections stained with Fluoro-Jade C (left and middle panels) and Mac-1 antibody (right panels). PBS controls (PBS/none) exhibit an absence of Fluoro-Jade C stained dead neurons on days 2 and 7, and only faint Mac-1 immunoreactivity on day 4 post-treatment. In MPTP-treated mice that received SPC from PBS/adjuvant treated donors (MPTP/PBS), Fluoro-Jade C stained neurons are evident at day 2, but not detectable by day 7. MPTP-treated mice that received SPC from 4YSyn immunized donors (MPTP/4YSyn), also exhibits dead fluorescent neurons by day 2 comparable to the MPTP/PBS control group, and only rare degenerating neurons are visible by day 7. Mac-1 immunoreactivity in those mice is comparably resolved to levels seen in MPTP/PBS control group. SPC transfers from N-4YSyn immunized donors to MPTP-treated mice (MPTP/N-4YSyn) induced a robust and prolonged microglial response, conspicuously enhanced when compared to MPTP/PBS-treated controls, with concomitant neuronal death still evident by Fluoro-Jade C staining at day 7.
###end p 87
###begin p 88
###xml 216 217 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 286 287 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 688 697 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g007">Figure 7A</xref>
###xml 772 773 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 808 817 804 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g007">Figure 7B</xref>
###xml 1142 1143 1138 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1223 1232 1219 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g007">Figure 7B</xref>
###xml 1329 1330 1325 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
Based on these findings, we next investigated whether the immune response mediated by N-alpha-Syn affects degeneration of dopaminergic cell bodies in the SNpc. To test this, MPTP-intoxicated B10.BR mice received 5x107 donor SPC from mice immunized with PBS, 4YSyn, or N-4YSyn, or 2.5x107 enriched T cells from 4YSyn-immunized donors. PBS- and MPTP-treated mice that did not receive cells served as controls for no neuronal loss and loss attributable to MPTP treatment alone, respectively. PBS-treated mice that received N-4YSyn immunized donor SPC served as additional controls. VMB sections were obtained from mice at 2, 7, and 28 days following MPTP treatment and immunostained for TH (Figure 7A). Stereological analysis showed that MPTP induced a 45% reduction of SN TH+ neurons compared to PBS controls (Figure 7B). Similar results were observed in MPTP-injected mice that received SPC from PBS or 4YSyn immune donors (MPTP/PBS/SPC and MPTP/4YSyn/SPC, respectively). In contrast, recipients that received immune N-4YSyn SPC (MPTP/N-4YSyn/SPC) or N-4YSyn T cells (MPTP/N-4YSyn/T Cells) exhibited significantly greater reductions of SNpc TH+ neurons (64 and 63%, respectively) compared to all other MPTP-treated animals (Figure 7B). PBS-treated mice that received immune SPC from N-4YSyn immunized donors showed no change in TH+ neuron numbers, demonstrating the necessity for an initiating neuronal insult. Significant effects from any treatment were not observed among the numbers of non-dopaminergic neurons (Nissl+TH-). Correlation analysis of total Nissl+ neurons compared to TH+ and TH- neurons demonstrated that the number of total neurons strongly correlated with numbers of TH+ neurons (r = 0.981, p<0.0001) compared to numbers of TH- neurons (r = 0.522, p = 0.004). This confirmed that differences in TH+ neuron counts are due to differences in numbers of structurally intact neurons and eliminates the possibility that differences resulted from the down-regulation of TH itself. Thus, these data demonstrate that adaptive immune responses against the nitrated form of alpha-Syn exacerbated MPTP-induced nigrostriatal degeneration.
###end p 88
###begin title 89
###xml 89 93 <span type="species:ncbi:10090">mice</span>
N-4YSyn immunization with adjuvant exacerbates dopaminergic neuronal cell loss in B10.BR mice.
###end title 89
###begin p 90
###xml 977 978 975 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1028 1029 1026 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1034 1035 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1041 1042 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
(A) All panels show TH-positive neurons in the SN from mice treated with: [top row, L to R] PBS or MPTP alone, MPTP and SPC from N-4YSyn immunized donors (MPTP+N-4YSyn), [bottom row, L to R] PBS and SPC from N-4YSyn immunized donors (PBS+N-4YSyn), MPTP and SPC from 4YSyn immunized donors (MPTP+4YSyn), and MPTP and T cells from N-4YSyn immunized donors (MPTP+N-4YSyn T Cells). Tissues collected 28 days post-MPTP treatment (B) Counts of nigral Nissl+ (blue bars), TH+ (red bars), and TH- (green bars) neurons on day 28 after MPTP treatment as determined by stereological analysis. Control groups included mice treated with PBS alone (n = 4), MPTP alone (n = 8), and PBS animals that received immune effector SPC from N-4YSyn immunized donor mice PBS/N-4YSyn/SPC (n = 6). Experimental groups included MPTP/PBS/SPC (n = 6), MPTP/4YSyn/SPC (n = 8), MPTP/N-4YSyn/SPC (n = 9), and MPTP mice which received purified T cells from N-4YSyn vaccinated donors. Values are means +/- SEM. p<0.01 compared to the following treatment groups: aPBS, bMPTP, cMPTP/4YSyn/SPC.
###end p 90
###begin p 91
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 192 193 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 298 299 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 459 460 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 530 539 518 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g008">Figure 8A</xref>
###xml 861 870 849 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g008">Figure 8B</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
Based on MHC binding affinity algorithms, mice expressing H-2b were predicted to respond poorly to alpha-Syn epitopes; yet 21 days after chronic MPTP-intoxication, B6 mice that express the H-2b haplotype yielded significant antibody responses to N-alpha-Syn. This suggested that mice expressing H-2b have the potential to develop immune responses to N-alpha-Syn that may affect disease progression. To assess that possibility, we immunized and boosted B6 (H-2b) mice with 4YSyn or N-4YSyn either in PBS or emulsified in adjuvant (Figure 8A). Five days after the final boost SPC were harvested, assessed for antigen specific lymphocyte proliferation, and adoptively transferred to MPTP-intoxicated recipients. Stimulation of SPC from PBS-treated controls indicated that neither 4YSyn nor N-4YSyn induced significant proliferation above medium background levels (Figure 8B). In contrast, stimulation of SPC from N-4YSyn/PBS immunized mice with N-4YSyn induced a significant lymphocyte proliferative response indicating that immunization with N-4YSyn/PBS in the absence of adjuvant is capable of inducing an antigen specific adaptive immunity.
###end p 91
###begin title 92
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Scheme for immunization, lymphocyte proliferation assessment, and adoptive transfer of donor SPC in B6 mice.
###end title 92
###begin p 93
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 531 532 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 754 755 742 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 995 996 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1167 1168 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 84 87 <span type="species:ncbi:31658">CFA</span>
###xml 124 127 <span type="species:ncbi:31658">CFA</span>
###xml 129 133 <span type="species:ncbi:10090">Mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 795 798 <span type="species:ncbi:31658">CFA</span>
###xml 810 813 <span type="species:ncbi:31658">CFA</span>
(A) B6 (H-2b) mice were immunized with 10 microg 4YSyn in PBS, 50 microg N-4YSyn in CFA, 10 microg N-4YSyn in PBS or PBS in CFA. Mice were boosted 14 days later with their respective antigens as formulated previously with or without IFA. After 5 days, single lymphoid cell suspensions were prepared and assessed for antigen-specific responses in standard lymphocyte proliferation assays. Single cell suspensions were pooled and adoptively transferred to MPTP-treated syngeneic recipients 12 hrs after the final MPTP injection. 5x107 donor immune SPC were adoptively transferred to MPTP-treated recipient mice. Survival of dopaminergic neurons in the SN of recipient mice were evaluated after 7 days. (B) Antigen specific proliferation of SPC from B6 (H-2b) mice (n = 5/group) immunized with PBS/CFA or N-4YSyn/CFA, and cultured for 5 days in media alone (green bars) or in the presence 1 microg/ml of 4YSyn (blue bars) or N-4YSyn (red bars). Cultures were pulsed for 18 hrs, cells harvested and 3H-thymidine incorporation counted by beta-scintillation spectrometry. Values represent mean stimulation indices+/-SEM and analyzed by ANOVA and Bonferroni post-hoc tests. ap = 0.0478.
###end p 93
###begin p 94
###xml 275 284 275 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g009">Figure 9A</xref>
###xml 620 629 620 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g009">Figure 9B</xref>
###xml 1586 1587 1578 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1588 1592 <span type="species:ncbi:10090">mice</span>
TH stained sections of VMB from MPTP-intoxicated mice that received SPC from donors immunized with N-4YSyn either in PBS excipient or adjuvant showed significant dopaminergic neuronal losses compared to MPTP-treated mice or those that received SPC from 4YSyn immunized mice (Figure 9A), suggesting 4YSyn immunization increased the MPTP-induced lesion. Next, we assessed the sections by stereological analysis to obtain estimates of dopaminergic neuronal survival and loss after treatment compared to PBS-treated mice. MPTP-intoxication of B6 mice induced 43% loss of TH+ nigral neurons compared to PBS-treated controls (Figure 9B). Numbers of dopaminergic neurons from MPTP mice treated with SPC from 4YSyn immunized mice were not significantly different compared to MPTP-treated mice and showed a similar 42% loss of neurons. However, adoptive transfer of SPC from N-4YSyn/Adjuvant immune donors significantly increased MPTP-induced dopaminergic neuron loss to 58%. Interestingly, SPC from mice immunized with N-4YSyn without adjuvant induced a 69% loss of nigral TH+ neurons after MPTP intoxication, which was significantly greater than losses due to SPC from 4YSyn- or N-4YSyn/Adjuvant immunized donors. Neither MPTP treatment nor adoptive transfer of immune SPC significantly affected numbers of non-dopaminergic neurons. Thus, taken together these data demonstrate that N-alpha-Syn, but not unmodified alpha-Syn, has the capacity to induce specific immune responses by which exacerbates neuronal loss in the context of dopaminergic neurodegeneration. Moreover, these results in H-2b mice, predicted to provide poor immune response, suggests that epitopes modified by inflammatory processes may function unlike their tolerated unmodified self-analogues to induce immune responses to levels sufficient to alter disease progression.
###end p 94
###begin title 95
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Lymphocytes from N-4YSyn immunization exacerbate nigral dopaminergic neuronal loss in B6 mice.
###end title 95
###begin p 96
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 565 573 563 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 590 591 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 625 626 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 658 659 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 701 702 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 235 238 <span type="species:ncbi:31658">CFA</span>
###xml 270 273 <span type="species:ncbi:31658">CFA</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 467 470 <span type="species:ncbi:31658">CFA</span>
(A) All panels show TH+ neurons in the SN from mice treated with PBS or MPTP alone, MPTP and SPC from 4YSyn immunized donors (MPTP+4YSyn), MPTP and SPC from N-4YSyn immunized donors (MPTP+N-4YSyn) and lastly, MPTP and SPC from N-4YSyn+CFA immunized donors (MPTP+N-4YSyn CFA). (B) Counts of nigral TH+ and TH- neurons on day 7 after MPTP treatment. Experimental groups included mice treated with PBS alone (n = 7), MPTP alone (n = 7), MPTP/4YSyn (n = 7), MPTP/N-4YSyn/CFA (n = 6) and MPTP/N-4YSyn (n = 6). Values are means +/- SEM. Analysis by ANOVA with Bonferroni post-hoc tests indicated ap<0.0001 compared to PBS control: bp<0.001 compared to MPTP group; cp<0.001 compared to MPTP/4YSyn group; and dp<0.03 compared to MPTP/4YSynCFA SPC.
###end p 96
###begin title 97
Nitrated alpha-Syn Inhibits Proliferation of Anti-CD3 Activated T Cells
###end title 97
###begin p 98
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 528 529 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sup>
###xml 694 703 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g010">Figure 10</xref>
###xml 842 843 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1023 1029 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Second</italic>
###xml 1399 1400 1391 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1450 1451 1442 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1467 1468 1459 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1492 1499 1484 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001376-t004">Table 4</xref>
###xml 1725 1726 1717 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1754 1755 1746 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1914 1915 1906 1907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
We observed that antigen specific proliferative responses were inhibited by N-4YSyn in a dose dependent manner (r2 = 0.96, p = 0.002). Significant inhibition was not seen by 4YSyn (r2 = 0.53, p = 0.273). To rule out an antigen specific suppressive effect, purified T cells obtained from naive mice were stimulated with anti-CD3 for 24 hrs in media or in the presence of 4YSyn or N-4YSyn at concentrations of 1, 3, 10 and 30 microg/ml. N-4YSyn inhibited proliferation of anti-CD3 stimulated T cells in a dose dependent fashion (rr = 0.6803, p<0.0001). A significant inhibition of 31 and 47% was observed when stimulated T cells were co-cultured at N-4YSyn concentrations of 10 and 30 microg/ml (Figure 10). In contrast, proliferation of anti-CD3 stimulated T cells was not inhibited by 4YSyn (p = 0.435) or by increasing 4YSyn concentration (r2 = 0.1554, p = 0.0854). Moreover, the inverse effect on anti-CD3 activated T cells with increasing N-4YSyn concentration was greater (p = 0.016) compared to that induced by 4YSyn. Second, to assess whether this effect was due to a cytotoxic mechanism, anti-CD3 stimulated T cells were stained for the membrane impermeant DNA dye, propidium iodide (PI) that is excluded from intact, living cells, and analyzed by flow cytometry. T cells cultured in the presence of N-4YSyn exhibited a dose-dependent increase in the mean fluorescent intensity (MFI) of PI (r2 = 0.9261, p = 0.0008) and in the percentage of PI+ dead T cells (r2 = 0.9743, p = 0.0018) (Table 4). In comparison, percentages of PI stained dead T cells cultured with 4YSyn and the PI MFI were not different from the basal level in absence of either of the peptides and did not change with increasing 4YSyn concentration (r2 = 0.5983, p = 0.1249, and r2 = 0.5016, p = 0.1807, respectively). Taken together, increasing N-4YSyn concentrations strongly correlated with inhibition of T cell proliferation, percent PI+ T cells, and increased MFI for PI (r>0.945, p<0.0154 for all comparisons combined). In contrast, no significant correlations were associated with increasing 4YSyn concentrations. Thus, cytotoxic interference of immune response induction by N-alpha-Syn may affect disease progression as these processes are shared by both effector and regulatory T cells.
###end p 98
###begin title 99
N-4YSyn-mediated inhibition of T cell proliferation.
###end title 99
###begin p 100
###xml 238 239 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 317 318 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 504 512 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 520 521 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Proliferative responses of anti-CD3 stimulated T cells from naive B6 mice in presence of graded concentrations of 4YSyn or N-4YSyn (1, 3, 10, 30 microg/ml) or in media alone (0 microg/ml). T cells were cultured for 72 hrs and pulsed with 3H-thymidine for the final 18 hrs of culture. Harvested cells were counted for 3H-thymidine uptake by beta-scintillation spectrometry and proliferation was expressed as mean counts per min (CPM)+/-SEM for quadruplicate samples and evaluated by ANOVA with Bonferroni post-hoc tests. ap<0.01 compared with T cells stimulated with anti-CD3 and cultured in media alone.
###end p 100
###begin title 101
N-4YSyn-induced cytotoxicity of stimulated T cells.
###end title 101
###begin p 102
Anti-CD3 stimulated T cells were cultured for 24 hrs in media alone or in the presence of different concentrations of 4YSyn or N-4YSyn, stained with 2 microg/ml of the vital dye, PI, washed, and assessed by flow cytometric analysis for uptake of PI.
###end p 102
###begin p 103
Percentage of T cells susceptible to PI permeation as determined by flow cytometric analysis.
###end p 103
###begin p 104
Mean fluorescence intensity of PI-stained T cells.
###end p 104
###begin p 105
###xml 357 361 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Young1">[88]</xref>
D statistic at alpha = 0.001 of Kolmogorov-Smirnov (K-S) analysis for fluorescence intensities of PI-stained T cells as the sigmoidal function of the accumulated cell frequency curve and fluorescence intensity (channel number) compared to the curve of PI-stained T cells from the medium control (asterisk) as computed by Cellquest software (BD Biosciences) [88].
###end p 105
###begin p 106
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sup>
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Young1">[88]</xref>
Index of similarity = D/[(nc+nt)/(nc.nt)]1/2, where nc and nt are the number of events in cell frequency curves for medium control (c) and test substance (t), respectively (BD Biosciences) [88]. An index of similarity = 0 indicates the curves are identical.
###end p 106
###begin title 107
N-4YSyn-Stimulated Immune SPC Enhance Dopaminergic Cell Death
###end title 107
###begin p 108
###xml 520 529 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g011">Figure 11</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
To directly test the neurotoxic capacity of the N-4YSyn immune response, proliferating T cells or supernatants from N-4YSyn stimulated SPC of N-4YSyn immunized mice were assessed in live/dead assays with co-cultures of N-alpha-Syn activated bone marrow-derived macrophages (BMM) and MES 23.5 cells. Minimal cytotoxicity was afforded from co-cultures of unstimulated BMM/MES 23.5 co-cultures with virtual 100% MES 23.5 cell survival, whereas activation with aggregated N-alpha-Syn resulted in 7% cell death after 24 hrs (Figure 11). Activated and proliferating T cells from 5 day cultures of antigen-specific stimulation of N-4YSyn immune SPC when added to activated BMM/MES 23.5 cultures induced 21% cell death (N-4YSyn+SPC), while supernatants (Sup) from those SPC cultures resulted in 44% cell death (N-4YSyn+SPC Sup), and no cytotoxicity to activated BMM cultured in the absence of MES 23.5 cells (Macrophages+SPC Sup). In transwell studies wherein N-4YSyn-stimulated BMM was separated from MES 23.5 targets, virtually all cytotoxicity was concentrated among the MES 23.5 cell population (MES 23.5 Transwell) with no cytotoxicity attributed to BMM. T cells isolated from N-4YSyn-immunized donors and re-stimulated in vitro with N-4Ysyn, but not 4YSyn, showed TNF-alpha levels (26.0+/-1.2 pg/ml) that were increased (p<0.008) compared to levels from T cells of either PBS or 4YSyn immunized mice which were below the limits of detection (data not shown).
###end p 108
###begin title 109
N-4YSyn activated immune SPC induces macrophage-mediated dopaminergic cell death.
###end title 109
###begin p 110
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1068 1076 1066 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 1125 1126 1123 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1133 1134 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1146 1147 1144 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Representative fluorescence photomicrographs are shown of live (green) and dead (red) cells from 24 hr macrophage/MES 23.5 co-cultures in the presence of media alone, N-4YSyn, N-4YSyn and antigen-stimulated SPC of N-4YSyn-immunized mice (N-4YSyn+SPC), or N-4YSyn and the supernatants from antigen-stimulated SPC of N-4YSyn-immunized mice (N-4YSyn+SPC Sup). Antigen-stimulated SPC from N-4YSyn immune mice were induced in vitro with N-4YSyn, and cells and supernatants for use in the assay were harvested after 5 days of culture. Controls included macrophages cultured in the presence of SPC supernatants from antigen-stimulated SPC of N-4YSyn-immunized mice (Macrophages+SPC Sup); macrophages cultured in the presence of N-4YSyn alone (Macrophages+N4YSyn); and transwell cultures of plated MES 23.5 cells and macrophages in the transwell stimulated with N-4YSyn. Frequencies (+/-SEM) of dead (red) cells for 4-8 fields/assay are provided in the lower right corner of each panel. Differences in the mean frequencies of dead cells were evaluated by ANOVA and Bonferroni post-hoc tests. p<0.01 compared to cultures treated with aMedia, bN-4YSyn, or cN-4YSyn+SPC.
###end p 110
###begin title 111
Discussion
###end title 111
###begin p 112
This study provides direct evidence that the adaptive immune system can exacerbate dopaminergic neuronal loss in animal models of PD. Nitrated proteins that drain from the CNS into lymphatics induce macrophage activation and T cell responses. Moreover, we show that these T cell responses to N-alpha-Syn elicit profound neurodegeneration. Cell damage resulting from N-alpha-Syn is not limited to brain cells as it affects both T cell function and numbers, and may, in fact, affect regulatory T cell subsets (Reynolds, et al. 2007, in press). Our data, taken together, suggests that an exacerbated immune response induced by N-alpha-Syn may play a role in PD pathogenesis.
###end p 112
###begin p 113
###xml 201 204 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Weinreb1">[6]</xref>
###xml 206 210 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Conway1">[50]</xref>
###xml 342 345 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Eliezer1">[7]</xref>
###xml 347 351 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Zhu1">[51]</xref>
###xml 353 357 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Zhu2">[52]</xref>
###xml 481 485 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-ElAgnaf2">[53]</xref>
###xml 691 695 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hodara1">[14]</xref>
###xml 697 701 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Uversky3">[16]</xref>
###xml 756 760 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hodara1">[14]</xref>
###xml 821 825 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Yamin1">[17]</xref>
###xml 827 831 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Conway1">[50]</xref>
###xml 933 937 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Volles1">[54]</xref>
###xml 997 1001 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Tanner1">[55]</xref>
###xml 1003 1007 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-DiMonte1">[56]</xref>
###xml 1158 1162 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Uversky4">[57]</xref>
Under homeostatic conditions alpha-Syn exists in equilibrium between soluble and lipid membrane bound forms. Unmodified soluble alpha-synuclein retains a native unfolded structure in its soluble state [6], [50] and exhibits an alpha-helical structure when membrane bound; the latter being less prone to fibrillation and nitrate modifications [7], [51], [52]. However under disease conditions, alpha-Syn develops a beta-pleated sheet configuration permissive for filament formation [53]. Nitrate modifications can prevent alpha-helical formation, increase beta-sheet and oligomer formation, and prolong the intracellular protein half-life by reducing the capacity for proteasomal degradation [14], [16]. Moreover, N-alpha-Syn can inhibit filament formation [14] resulting in increased formation of oligomeric protofibrils [17], [50]. Such oligomeric protofibrils are cytotoxic through pore-forming activity within the plasma membrane [54]. Likewise, environmental cues are known to be linked to PD [55], [56] and elicit significant effects on intraneuronal concentrations, post-translation modifications, conformational behavior, and aggregation of alpha-Syn [57]. These observations, taken together, support an environmental role for sporadic PD.
###end p 113
###begin p 114
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Imamura1">[58]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-McGeer1">[59]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Hisanaga1">[60]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Fiszer1">[61]</xref>
###xml 605 609 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Fiszer2">[62]</xref>
###xml 611 615 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Fiszer3">[63]</xref>
###xml 685 686 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 732 733 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 764 765 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 829 833 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Fiszer1">[61]</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 962 967 <span type="species:ncbi:9606">human</span>
Peripheral immune abnormalities have been widely described in PD including the occurrence of autoantibodies against neuronal structures and high numbers of microglia cells expressing human leukocyte antigen (HLA)-DR in the nigrostriatal system [58], [59]. Disturbed cellular and humoral immune functions in peripheral blood of patients with PD have been also identified and T cell infiltration of diseased CNS tissues have been reported [60], [61]. An elevated T cell population expressing gamma/delta T cell receptors and increased IgG levels in CSF to heat shock proteins have been also described in PD [62], [63]. T helper cell analysis has revealed a decreased percentage of CD45RA+ "naive" and an increased percentage of CD45RO+ "memory" T cell subsets in CD4+ T cell populations in the peripheral blood of patients with PD [61]. Collectively, these studies suggest that perturbations in the adaptive immune system may play a role in the progression of the human disease.
###end p 114
###begin p 115
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-McGeer1">[59]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Lampe1">[64]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Le1">[65]</xref>
###xml 443 454 <span type="species:ncbi:10141">guinea pigs</span>
###xml 498 501 <span type="species:ncbi:31658">CFA</span>
###xml 684 687 <span type="species:ncbi:10116">rat</span>
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
###xml 788 798 <span type="species:ncbi:10141">guinea pig</span>
###xml 929 934 <span type="species:ncbi:10090">mouse</span>
###xml 938 941 <span type="species:ncbi:10116">rat</span>
###xml 994 1004 <span type="species:ncbi:10141">guinea pig</span>
There is mounting evidence that immune abnormalities exist in PD. Increased HLA expression, CNS T cell infiltration [59], IgG1 deposition in Lewy Bodies, and peripheral immune abnormalities have been reported. Moreover, the recently demonstrated significant increase of the DQB1*06 MHC class II allele in idiopathic PD may indicate an association between sporadic PD and the immune system [64]. Le and colleagues reported that immunization of guinea pigs with homogenized MES 23.5 cell extracts in CFA resulted in nigrostriatal injury demonstrating the capability of adaptive immune components to injure dopaminergic neurons [65]. However, this approach used a cell line derived from rat embryonic mesencephalon cells that were fused with mouse neuroblastoma cells as an immunogen in the guinea pig. This experimental strategy precludes the challenge of breaking tolerance to self, the primary hurdle in autoimmune pathology, as mouse or rat proteins would likely be viewed as "foreign" in the guinea pig. Moreover, this work models PD as a primary autoimmune disease, for which little supporting evidence exists, and does not give any indication as to how, or under what circumstances, such autoimmune reactions may occur. Our data provides a rationale and a novel mechanism, which includes immunity to modified self-proteins as a disease modifier, rather than autoimmunity as a primary pathological mechanism. This idea nicely supports existing hypotheses where toxic injury (environmental or endogenous) results in damaged self-proteins capable of immune activation. Adaptive immune responses may play a role in amplifying and sustaining innate immune mechanisms operative in PD. Moreover, this may provide insight as to why antigenically related sites are also affected in PD such as the locus coeruleus, raphe nuclei, and nucleus basalis of Meynert.
###end p 115
###begin p 116
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Liberatore1">[66]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Wu2">[67]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Langston1">[68]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-McGeer2">[69]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Kaplan1">[70]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Kosiewicz1">[71]</xref>
###xml 2036 2041 2028 2033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">First</italic>
###xml 2185 2189 2177 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Wenkel1">[72]</xref>
###xml 2191 2197 2183 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Second</italic>
###xml 2396 2401 2388 2393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Third</italic>
###xml 2463 2467 2451 2455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Przedborski2">[73]</xref>
###xml 2511 2512 2499 2500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2525 2526 2513 2514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2763 2764 2747 2748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2777 2778 2761 2762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2872 2873 2856 2857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 2894 2895 2878 2879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3327 3330 3299 3302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 3338 3341 3310 3313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">133</sup>
###xml 3388 3392 3356 3360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Giasson1">[74]</xref>
###xml 3471 3475 3439 3443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Sacksteder1">[75]</xref>
###xml 3572 3576 3540 3544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Souza1">[76]</xref>
###xml 3688 3697 3652 3661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001376-g003">Figure 3A</xref>
###xml 171 175 <span type="species:ncbi:10090">Mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 530 535 <span type="species:ncbi:10090">mouse</span>
###xml 542 548 <span type="species:ncbi:9606">humans</span>
###xml 557 562 <span type="species:ncbi:9606">human</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
###xml 2106 2110 <span type="species:ncbi:10090">mice</span>
###xml 2494 2498 <span type="species:ncbi:10090">mice</span>
###xml 3097 3105 <span type="species:ncbi:9606">patients</span>
###xml 3173 3177 <span type="species:ncbi:10090">mice</span>
###xml 3182 3187 <span type="species:ncbi:9606">human</span>
Innate neuroinflammatory reactions, primarily associated with activated microglia, significantly contributes to secondary neuronal loss in animal models of PD [66], [67]. Mice intoxicated with an acute regimen of MPTP exhibit a robust inflammatory response, which precedes neuronal loss and resolves by day 4 post-intoxication during which most degeneration takes place. The acute nature of this inflammatory response seen in mice is in striking contrast to idiopathic PD that slowly progresses over a period of years. Unlike the mouse data, humans and non-human primates intoxicated with MPTP have sustained microglial activation [68], [69]. Mechanisms linking innate immune activation and dopaminergic neuronal cell loss are under active study. One potential mechanism for sustaining innate neuroinflammatory reactions includes peripheral activation of the adaptive immune system against CNS antigens originating in damaged tissue. Foreign antigen introduced into CNS compartments, including the anterior chamber of the eye or striatum [70], results in the education of peripheral T cells in the spleen or CLN, respectively, and primarily favors tolerance induction [71]. Interestingly, dendritic cells populate perivascular regions of the CNS in normal physiological and pathological states, and have been proposed to migrate out of the CNS where they may act as APC in secondary lymphoid organs. "New" brain antigens (foreign or modified self) presented to the immune system during CNS inflammatory disease states may not favor tolerance induction. Here, we first detected a NT-modified protein with molecular mass <20 kD within the CLN of MPTP-treated mice, which was not observed in any other lymphoid tissue examined. Later this NT-modified protein was unambiguously identified as alpha-Syn by IP with N-alpha-Syn specific antibody and in-gel tryptic digestion with protein sequencing by LC MS/MS of the 12-18 kD band after 1D-SDS PAGE. Several lines of evidence support the possibility of drainage of CNS antigens into the CLN. First, ovalbumin (OVA) antigen directly injected into the striatum of mice resulted in antigen-specific T cell education exclusively in the deep CLN [72]. Second, in our model system, MBP, which is specific to the CNS, was also identified by Western blot at the same time suggesting that brain-derived antigens were draining to the CLN post-MPTP intoxication. Third, peroxynitrite favors nitration of Tyr residues on alpha-Syn [73]. Two different strains of mice, B10.BR (H-2k) and B6 (H-2b), expressing disparate MHC haplotypes were employed. Predictions of MHC binding affinities for alpha-Syn T cell epitopes suggested an increased number of peptides with intermediate and high degree binding to class I MHC molecules of H-2k, but not H-2b. An overall stronger immunogenic binding potential even to MHC class II was predicted for H-2k when compared to H-2b. These predictions suggested the 2 strains would exhibit different levels of T cell responses to N-alpha-Syn with consequential heterogeneous outcomes affecting disease. It is not clear, whether in PD patients the C-terminal fragment of alpha-Syn, which is nearly identical in mice and human, is nitrated. However, earlier studies demonstrated that monoclonal antibodies to N-alpha-Syn recognize fragments that include nitrated Tyr125 and Tyr133 residues within alpha-Syn C-terminal fragment [74]. Recent studies confirmed preference of NT in close proximity to carboxylates [75]. This is consistent with previous data that promote nitration of Tyr by nearby negative charges [76]. Indeed, within the Tyr-containing 42 aa C-terminal of alpha-Syn more than 28% (12 aa) are charged negatively (Figure 3A). All together, we posit that monitoring of T cell responses to epitopes predicted in this study may determine the association of neurodegeneration and alpha-Syn immune responses.
###end p 116
###begin p 117
###xml 604 612 600 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1936 1940 1932 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Rommelfanger1">[77]</xref>
###xml 1942 1946 1938 1942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Tillerson1">[78]</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
###xml 1341 1345 <span type="species:ncbi:10090">mice</span>
###xml 1489 1493 <span type="species:ncbi:10090">mice</span>
###xml 1520 1523 <span type="species:ncbi:31658">CFA</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
###xml 1888 1892 <span type="species:ncbi:10090">mice</span>
The focus of the current study was to elucidate and characterize new cellular and molecular mechanisms that explain the prolonged neuroinflammation and progressive dopaminergic neurodegeneration in PD as modeled by the administration of MPTP. B10.BR or B6 mice immunized with the unmodified C-terminal tail of alpha-Syn failed to generate detectable proliferative responses after SPC were stimulated with 4YSyn or N-4YSyn, thus suggesting a degree of tolerance to this self-protein. Conversely, both strains of mice immunized with N-4YSyn developed robust proliferative responses to the modified protein in vitro. Interestingly, immune cells that recognized only the modified form did not proliferate in response to the unmodified form suggesting a high degree of specificity in generating adaptive immune responses to the nitrated epitope. Exacerbation of dopaminergic neuronal loss in both MPTP-intoxicated B6 and B10.BR mice that received N-4YSyn immune cells from syngeneic donors was observed in our studies. The loss of dopaminergic neurons within the SN of those recipient mice was significantly greater compared to MPTP-treated animals or those that received SPC from mice immunized with 4YSyn or PBS. Transfer of SPC from mice immunized with unmodified 4YSyn yielded no difference in SN dopaminergic neuronal loss compared to those mice treated with MPTP alone. Importantly, the transfer of purified T cells from N-4YSyn immunized donors exacerbated nigral degeneration in B10.BR mice. Elimination of adjuvant (CFA/IFA) from the immunization strategy for B6 donors and subsequent adoptive transfer of N-4YSyn immune SPC produced the most severe dopaminergic neuronal losses. While behavioral testing of MPTP mice was considered to substantiate dopaminergic neurodegeneration, those were not performed as rodents do not develop typical parkinsonism and behavioral testing in MPTP mice has not proven to be consistently reliable [77], [78].
###end p 117
###begin p 118
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 251 259 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 933 937 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Bard1">[79]</xref>
###xml 939 943 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Schenk1">[80]</xref>
###xml 1318 1322 1304 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Check1">[81]</xref>
###xml 1324 1328 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Nicoll1">[82]</xref>
###xml 1330 1334 1316 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Orgogozo1">[83]</xref>
###xml 1712 1713 1698 1699 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1716 1717 1702 1703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1741 1745 1727 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Faria1">[84]</xref>
###xml 1747 1751 1733 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001376-Weiner1">[85]</xref>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
While the exact phenotype of the T cell response generated in this vaccination strategy is unknown, a proinflammatory TH1 response was likely generated and associated with exacerbation of inflammatory responses and neurotoxicity. We also demonstrated in vitro that antigen-activated immune responses to N-4YSyn augment N-4YSyn-induced, cell-mediated dopaminergic toxicity with macrophages activated by N-alpha-Syn, linked to an induction of TNF-alpha production by stimulated T cells. This suggests a potent mechanism for exacerbation of inflammatory responses and progression of dopaminergic neurodegenerative processes conferred by N-4YSyn specific T cells. These data also emphasize caution in design of vaccine-based therapeutic strategies for PD or other neurodegenerative disorders. Recently, a promising Abeta vaccine strategy was employed in transgenic amyloid precursor protein (APP) mice as a model for Alzheimer's disease [79], [80]. In these studies, immunized APP transgenic animals showed markedly reduced Abeta deposition, preservation of normal neuronal structures, and improved performance in memory and spatial learning tasks. After completing a successful phase I trial with no significant toxicities, phase II trials came to an abrupt end when 15 vaccine recipients experienced meningoencephalitis [81], [82], [83]. Clearly, immune system can generate T cell responses to proteins that are similarly modified as those found in PD but alternative routes of administration may generate entirely different effects on the disease process and as such do not preclude using these proteins as potential vaccine candidates. For example, nasal administration favors the generation of regulatory type TH2/TH3 responses to antigens [84], [85]. Mucosal vaccination using N-4YSyn may result in dramatically different results than those presented here.
###end p 118
###begin p 119
All together, we demonstrated for the first time, that NT alpha-Syn modifications circumvent immunological tolerance. We posit that these observations are directly relevant to the tempo and progression of PD. Indeed, NT-modifications of alpha-Syn are present in Lewy bodies during disease and when present in the extracellular spaces of the brain appears in the CNL where a robust adaptive immune response is produced that accelerates nigral dopaminergic neuronal degeneration. Most importantly the abilities of N-alpha-Syn to evade immunological tolerance provides a novel pathogenic mechanism for PD and new opportunities for therapeutic intervention.
###end p 119
###begin p 120
The authors thank Drs. Jianuo Liu and Wojciech Rozek and Mr. Joshua D Schlautman for technical assistance for the Western blot and LC-MS/MS analyses. We authors are indebted to Dr. Eliezer Masliah and Ms. Robin Taylor for critical reading of the manuscript.
###end p 120
###begin title 121
References
###end title 121
###begin article-title 122
Parkinson's disease: mechanisms and models.
###end article-title 122
###begin article-title 123
Parkinson's disease: clinical aspects.
###end article-title 123
###begin article-title 124
Alpha-synuclein in Lewy bodies.
###end article-title 124
###begin article-title 125
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
###end article-title 125
###begin article-title 126
Induction of alpha-synuclein aggregation by intracellular nitrative insult.
###end article-title 126
###begin article-title 127
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.
###end article-title 127
###begin article-title 128
Conformational properties of alpha-synuclein in its free and lipid-associated states.
###end article-title 128
###begin article-title 129
Why are "natively unfolded" proteins unstructured under physiologic conditions?
###end article-title 129
###begin article-title 130
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
###end article-title 130
###begin article-title 131
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
###end article-title 131
###begin article-title 132
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
###end article-title 132
###begin article-title 133
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
###end article-title 133
###begin article-title 134
alpha-Synuclein locus triplication causes Parkinson's disease.
###end article-title 134
###begin article-title 135
Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.
###end article-title 135
###begin article-title 136
Evidence for a partially folded intermediate in alpha-synuclein fibril formation.
###end article-title 136
###begin article-title 137
Effects of nitration on the structure and aggregation of alpha-synuclein.
###end article-title 137
###begin article-title 138
###xml 35 40 <span type="species:ncbi:9606">human</span>
Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers.
###end article-title 138
###begin article-title 139
An inflammatory pathomechanism for Parkinson's disease?
###end article-title 139
###begin article-title 140
Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
###end article-title 140
###begin article-title 141
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition.
###end article-title 141
###begin article-title 142
Oxidative and antioxidative potential of brain microglial cells.
###end article-title 142
###begin article-title 143
Oxidative stress and nitration in neurodegeneration: cause, effect, or association?
###end article-title 143
###begin article-title 144
Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins.
###end article-title 144
###begin article-title 145
Systemic exposure to irradiated apoptotic cells induces autoantibody production.
###end article-title 145
###begin article-title 146
Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis.
###end article-title 146
###begin article-title 147
The key role of nucleosomes in lupus.
###end article-title 147
###begin article-title 148
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
Chicken and egg in autoimmunity and joint inflammation.
###end article-title 148
###begin article-title 149
Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.
###end article-title 149
###begin article-title 150
Post-translational protein modifications in antigen recognition and autoimmunity.
###end article-title 150
###begin article-title 151
Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response.
###end article-title 151
###begin article-title 152
Neural immunity: Friend or foe?
###end article-title 152
###begin article-title 153
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity.
###end article-title 153
###begin article-title 154
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.
###end article-title 154
###begin article-title 155
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.
###end article-title 155
###begin article-title 156
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.
###end article-title 156
###begin article-title 157
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
###end article-title 157
###begin article-title 158
Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons.
###end article-title 158
###begin article-title 159
###xml 51 79 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease.
###end article-title 159
###begin article-title 160
Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations.
###end article-title 160
###begin article-title 161
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia.
###end article-title 161
###begin article-title 162
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome.
###end article-title 162
###begin article-title 163
Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation.
###end article-title 163
###begin article-title 164
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells.
###end article-title 164
###begin article-title 165
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 75 85 <span type="species:ncbi:7227">Drosophila</span>
Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages.
###end article-title 165
###begin article-title 166
Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
###end article-title 166
###begin article-title 167
Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.
###end article-title 167
###begin article-title 168
###xml 107 112 <span type="species:ncbi:9606">human</span>
Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.
###end article-title 168
###begin article-title 169
A community resource benchmarking predictions of peptide binding to MHC-I molecules.
###end article-title 169
###begin article-title 170
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
###end article-title 170
###begin article-title 171
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
###end article-title 171
###begin article-title 172
The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation.
###end article-title 172
###begin article-title 173
Lipid binding inhibits alpha-synuclein fibril formation.
###end article-title 173
###begin article-title 174
###xml 109 114 <span type="species:ncbi:9606">human</span>
Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments.
###end article-title 174
###begin article-title 175
Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.
###end article-title 175
###begin article-title 176
Occupational and environmental causes of parkinsonism.
###end article-title 176
###begin article-title 177
Environmental factors in Parkinson's disease.
###end article-title 177
###begin article-title 178
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
###end article-title 178
###begin article-title 179
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains.
###end article-title 179
###begin article-title 180
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
###end article-title 180
###begin article-title 181
Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease.
###end article-title 181
###begin article-title 182
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood.
###end article-title 182
###begin article-title 183
###xml 38 46 <span type="species:ncbi:9606">patients</span>
gamma delta+ T cells are increased in patients with Parkinson's disease.
###end article-title 183
###begin article-title 184
Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease.
###end article-title 184
###begin article-title 185
HLA typing and Parkinson's disease.
###end article-title 185
###begin article-title 186
###xml 41 52 <span type="species:ncbi:10141">guinea pigs</span>
Experimental autoimmune nigral damage in guinea pigs.
###end article-title 186
###begin article-title 187
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
###end article-title 187
###begin article-title 188
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
###end article-title 188
###begin article-title 189
###xml 70 76 <span type="species:ncbi:9606">humans</span>
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.
###end article-title 189
###begin article-title 190
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
###end article-title 190
###begin article-title 191
Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation.
###end article-title 191
###begin article-title 192
Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
###end article-title 192
###begin article-title 193
Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier.
###end article-title 193
###begin article-title 194
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
###end article-title 194
###begin article-title 195
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
###end article-title 195
###begin article-title 196
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease.
###end article-title 196
###begin article-title 197
Factors determining the selectivity of protein tyrosine nitration.
###end article-title 197
###begin article-title 198
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.
###end article-title 198
###begin article-title 199
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
###end article-title 199
###begin article-title 200
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
###end article-title 200
###begin article-title 201
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
###end article-title 201
###begin article-title 202
Nerve inflammation halts trial for Alzheimer's drug.
###end article-title 202
###begin article-title 203
###xml 18 23 <span type="species:ncbi:9606">human</span>
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.
###end article-title 203
###begin article-title 204
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.
###end article-title 204
###begin article-title 205
Oral tolerance.
###end article-title 205
###begin article-title 206
Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.
###end article-title 206
###begin article-title 207
MHCPred: bringing a quantitative dimension to the online prediction of MHC binding.
###end article-title 207
###begin article-title 208
MHCPred: A server for quantitative prediction of peptide-MHC binding.
###end article-title 208
###begin article-title 209
Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.
###end article-title 209
###begin p 210
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 210
###begin p 211
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by grants from the National Institute of Neurological Disorders and Stroke Grants (NS36136, NS43985, NS007488, NS42269, NS38370, NS11766 and NS049264); National Institute of Mental Health (MH64570); National Institute of Aging (AG021617); National Institute of Environmental Health Sciences (ES013177); U.S. Department of Defense Grant (17-03-1); the Parkinson's Disease Foundation (CU51523606) and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 211

